(609736, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609737, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609738, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609739, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609740, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609741, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000921', 'demyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609742, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0006080', 'brain ischemia', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609743, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002578', 'impaired ability to fire action potentials', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609744, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609745, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609746, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609747, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609748, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609749, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609750, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609751, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609752, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004994', 'abnormal brain wave pattern', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609753, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000947', 'convulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609754, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609755, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001915', 'intracranial hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609756, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003468', 'increased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609757, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002195', 'psychomotor seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609758, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609759, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0021015', 'increased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609760, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009142', 'decreased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609761, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005403', 'abnormal nerve conduction', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609762, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609763, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609764, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002915', 'abnormal synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609765, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003218', 'decreased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609766, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002914', 'abnormal endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609767, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609768, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003486', 'abnormal channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609769, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003485', 'abnormal channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609770, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609771, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609772, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609773, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011397', 'endoneurial edema', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609774, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609775, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003990', 'decreased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609776, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609777, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001499', 'abnormal kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609778, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609779, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609780, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609781, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609782, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609783, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0021001', 'impaired neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609784, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609785, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003635', 'abnormal synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609786, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609787, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609788, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609789, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609790, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609791, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012006', 'abnormal hippocampus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609792, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609793, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609794, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003489', 'increased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609795, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004835', 'abnormal miniature endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609796, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609797, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609798, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609799, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609800, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004494', 'abnormal synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609801, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002923', 'increased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609802, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609803, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609804, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609805, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003469', 'decreased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609806, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609807, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609808, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001473', 'reduced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609809, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012011', 'febrile seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609810, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0014253', 'decreased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609811, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609812, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003480', 'increased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609813, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609814, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609815, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609816, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609817, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609818, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009141', 'increased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609819, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609820, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609821, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002916', 'increased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609822, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003476', 'decreased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609823, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609824, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609825, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002064', 'seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609826, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609827, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609828, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003487', 'increased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609829, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609830, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609831, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003216', 'absence seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609832, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609833, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609834, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609835, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609836, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609837, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0021010', 'impaired synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609838, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003470', 'abnormal summary potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609839, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609840, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609841, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609842, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609843, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609844, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609845, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609846, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609847, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005402', 'abnormal action potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609848, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609849, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609850, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609851, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609852, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609853, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609854, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609855, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609856, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003490', 'decreased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609857, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002207', 'abnormal long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609858, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003482', 'increased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609859, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609860, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609861, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609862, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609863, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609864, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609865, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011994', 'increased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609866, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609867, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0006058', 'decreased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609868, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609869, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609870, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609871, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609872, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609873, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609874, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609875, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003996', 'clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609876, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003484', 'abnormal channel response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609877, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003474', 'abnormal summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609878, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609879, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609880, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003464', 'abnormal single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609881, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002193', 'minimal clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609882, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609883, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609884, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008840', 'abnormal spike wave discharge', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609885, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0021009', 'abnormal synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609886, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609887, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609888, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003463', 'abnormal single cell response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609889, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609890, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609891, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009358', 'environmentally induced seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609892, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609893, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609894, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609895, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003488', 'decreased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609896, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609897, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609898, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003467', 'abnormal single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609899, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004859', 'abnormal synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609900, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609901, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609902, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609903, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609904, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609905, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609906, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609907, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609908, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609909, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609910, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0013438', 'dysmyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609911, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609912, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609913, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609914, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609915, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003219', 'increased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609916, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001900', 'impaired synaptic plasticity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609917, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609918, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0006054', 'spinal hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609919, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003008', 'enhanced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609920, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609921, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609922, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609923, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609924, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609925, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609926, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002826', 'tonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609927, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609928, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000951', 'sporadic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609929, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003472', 'increased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609930, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609931, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002917', 'decreased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609932, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609933, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004811', 'abnormal neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609934, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0014255', 'increased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609935, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002920', 'decreased paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609936, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609937, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609938, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609939, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003088', 'abnormal prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609940, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609941, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609942, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008814', 'decreased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609943, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609944, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609945, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609946, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009967', 'abnormal neuron proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609947, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609948, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609949, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003465', 'increased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609950, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609951, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001898', 'abnormal long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609952, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008921', 'increased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609953, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609954, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003633', 'abnormal nervous system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609955, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609956, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609957, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609958, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002634', 'abnormal sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609959, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609960, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003217', 'increased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609961, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609962, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0013806', 'encephalopathy', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609963, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609964, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003220', 'decreased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609965, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609966, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0010050', 'hypermyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609967, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0020424', 'increased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609968, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609969, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609970, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609971, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609972, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609973, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003997', 'tonic-clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609974, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609975, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609976, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000948', 'nonconvulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609977, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609978, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609979, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609980, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609981, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609982, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609983, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004513', 'avnosmia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609984, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609985, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609986, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003880', 'abnormal central pattern generator function', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609987, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609988, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609989, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609990, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609991, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609992, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000920', 'abnormal myelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609993, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003473', 'decreased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609994, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0014120', 'focal seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(609995, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609996, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609997, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609998, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(609999, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003889', 'enhanced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610000, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610001, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0006060', 'increased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610002, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001500', 'decreased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610003, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001496', 'audiogenic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610004, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610005, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610006, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610007, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610008, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610009, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004768', 'abnormal axonal transport', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610010, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003471', 'abnormal summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610011, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610012, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002635', 'reduced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610013, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610014, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610015, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610016, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610017, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0014254', 'increased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610018, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610019, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610020, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610021, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0003475', 'increased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610022, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610023, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610024, 'HP:0007272', 'Progressive psychomotor deterioration', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610025, 'HP:0011560', 'Mitral atresia', 'MP:0010618', 'enlarged mitral valve', 0.41818181818181815, 12.66854781257542, 2.3016855471558415, 'UPHENO:0076757', 'abnormal mitral valve morphology'),
(610026, 'HP:0011560', 'Mitral atresia', 'MP:0010619', 'patent mitral valve', 0.4339622641509434, 12.66854781257542, 2.344711430485575, 'UPHENO:0076757', 'abnormal mitral valve morphology'),
(610027, 'HP:0011560', 'Mitral atresia', 'MP:0006119', 'mitral valve atresia', 0.42592592592592593, 12.66854781257542, 2.322899687289154, 'UPHENO:0076757', 'abnormal mitral valve morphology'),
(610028, 'HP:0011560', 'Mitral atresia', 'MP:0006121', 'calcified mitral valve', 0.42592592592592593, 12.66854781257542, 2.322899687289154, 'UPHENO:0076757', 'abnormal mitral valve morphology'),
(610029, 'HP:0009116', 'Aplasia/Hypoplasia involving bones of the skull', 'MP:0010031', 'abnormal cranium size', 0.40384615384615385, 7.173214147510782, 1.7020208412904487, 'UPHENO:0081566', 'abnormal skull morphology'),
(610030, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0009037', 'abnormal subarachnoid space development', 0.40540540540540543, 12.214829845132515, 2.225299540584142, 'UPHENO:0075672', 'abnormal meninx'),
(610031, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0002229', 'neurodegeneration', 0.40540540540540543, 5.028460092616607, 1.4277832126804608, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(610032, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0000956', 'decreased spinal cord size', 0.4358974358974359, 9.69625474174526, 2.055862976887106, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(610033, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0005623', 'abnormal meninges morphology', 0.4117647058823529, 12.214829845132515, 2.242684957497146, 'UPHENO:0075672', 'abnormal meninx'),
(610034, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0009027', 'abnormal subarachnoid space morphology', 0.4166666666666667, 12.214829845132515, 2.255994777359177, 'UPHENO:0075672', 'abnormal meninx'),
(610035, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0003086', 'hydromyelia', 0.4146341463414634, 9.69625474174526, 2.005093091991719, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(610036, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0009023', 'abnormal spinal cord meninges morphology', 0.4722222222222222, 14.732678149995134, 2.637631137076502, 'UPHENO:0087287', 'abnormal meninx of spinal cord morphology'),
(610037, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0030014', 'calcified brain', 0.42105263157894735, 5.838687225017717, 1.567926854499307, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(610038, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0000955', 'abnormal spinal cord morphology', 0.4117647058823529, 9.69625474174526, 1.9981430083692977, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(610039, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0012712', 'spinal cord degeneration', 0.4473684210526316, 9.69625474174526, 2.0827381433916914, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(610040, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0002809', 'increased spinal cord size', 0.4358974358974359, 9.69625474174526, 2.055862976887106, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(610041, 'HP:0010304', 'Spinal meningeal diverticulum', 'MP:0000771', 'abnormal brain size', 0.42105263157894735, 5.838687225017717, 1.567926854499307, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(610042, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610043, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610044, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011534', 'granular kidney', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610045, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610046, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610047, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0000527', 'abnormal kidney development', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610048, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610049, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0004195', 'abnormal kidney calyx morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610050, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610051, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610052, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0009860', 'nephrosclerosis', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610053, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011383', 'abnormal kidney capsule morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610054, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0004969', 'pale kidney', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610055, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011364', 'abnormal metanephros morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610056, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610057, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610058, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610059, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0012024', 'abnormal nephron morphogenesis', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610060, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011382', 'abnormal kidney lobule morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610061, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610062, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0003881', 'abnormal nephron morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610063, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0002135', 'abnormal kidney morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610064, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0003613', 'abnormal kidney medulla development', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610065, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610066, 'HP:0033897', 'Arcuate artery lumen cholesterol emboli', 'MP:0011402', 'renal cast', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610067, 'HP:0033319', 'Fibrous crescent', 'MP:0003197', 'nephrocalcinosis', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610068, 'HP:0033319', 'Fibrous crescent', 'MP:0002706', 'abnormal kidney size', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610069, 'HP:0033319', 'Fibrous crescent', 'MP:0003985', 'renal fibrosis', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610070, 'HP:0033319', 'Fibrous crescent', 'MP:0011293', 'dilated nephron', 0.40816326530612246, 8.69825431939161, 1.8842260706894922, 'UPHENO:0076756', 'abnormal nephron morphology'),
(610071, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0003197', 'nephrocalcinosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610072, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0011360', 'kidney cortex hypoplasia', 0.4166666666666667, 10.972941248170269, 2.1382373239199337, 'UPHENO:0019594', 'abnormal cortex of kidney morphology'),
(610073, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0002955', 'increased compensatory renal growth', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610074, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.40476190476190477, 9.252530554317739, 1.9352188225193994, 'UPHENO:0086686', 'abnormal cortex of kidney morphology'),
(610075, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0003985', 'renal fibrosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610076, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0004968', 'kidney epithelium hyperplasia', 0.41304347826086957, 8.472720947690348, 1.8707223552862549, 'UPHENO:0087993', 'abnormal kidney epithelium morphology'),
(610077, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.4090909090909091, 9.252530554317739, 1.9455400627736394, 'UPHENO:0086686', 'abnormal cortex of kidney morphology'),
(610078, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0009641', 'kidney degeneration', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610079, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0011293', 'dilated nephron', 0.425531914893617, 8.69825431939161, 1.9238983384686383, 'UPHENO:0076756', 'abnormal nephron morphology'),
(610080, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0003670', 'dilated renal glomerular capsule', 0.40384615384615385, 9.252530554317739, 1.9330284213392313, 'UPHENO:0086686', 'abnormal cortex of kidney morphology'),
(610081, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0003881', 'abnormal nephron morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(610082, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0002706', 'abnormal kidney size', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610083, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0011377', 'renal glomerulus fibrosis', 0.4117647058823529, 9.252530554317739, 1.9518876818009092, 'UPHENO:0086686', 'abnormal cortex of kidney morphology'),
(610084, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.40384615384615385, 9.252530554317739, 1.9330284213392313, 'UPHENO:0086686', 'abnormal cortex of kidney morphology'),
(610085, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0002956', 'decreased compensatory renal growth', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610086, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0011402', 'renal cast', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(610087, 'HP:0033312', 'Abnormal Bowman space morphology', 'MP:0012024', 'abnormal nephron morphogenesis', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(610088, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0020403', 'lysinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610089, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030689', 'cystathioninuria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610090, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030612', 'organic aciduria', 0.43636363636363634, 10.430558536187952, 2.133428333025214, 'UPHENO:0068144', 'increased level of organic acid in urine'),
(610091, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030613', 'dicarboxylic aciduria', 0.5517241379310345, 10.47786425096631, 2.404348273695554, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610092, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0011470', 'increased urine creatinine level', 0.40298507462686567, 9.50911518495075, 1.9575575323455603, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(610093, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0020401', 'argininuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610094, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0020400', 'cystinuria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610095, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0011516', 'aspartylglucosaminuria', 0.47761194029850745, 10.47786425096631, 2.237041142913645, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610096, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0011517', 'hyperoxaluria', 0.49230769230769234, 10.47786425096631, 2.271196418125586, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610097, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0002931', 'glutaricadicuria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610098, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0020405', 'taurinuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610099, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0011654', 'histidinuria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610100, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0020402', 'ornithinuria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610101, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030616', 'hyperglycinuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610102, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0020404', 'prolinuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610103, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030682', 'hydroxyprolinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610104, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0020406', 'hyperthreoninuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610105, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610106, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030615', 'ethylmalonic aciduria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610107, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030618', 'tryptophanuria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610108, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030620', 'valinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610109, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0013730', 'glutathionuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610110, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030614', 'methylmalonic aciduria', 0.47761194029850745, 10.47786425096631, 2.237041142913645, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610111, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0011765', 'oroticaciduria', 0.5245901639344263, 10.47786425096631, 2.344479585131225, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610112, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0003311', 'aminoaciduria', 0.48484848484848486, 10.47786425096631, 2.253924711814731, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610113, 'HP:0034653', 'Monocarboxylic aciduria', 'MP:0030617', 'hyperglutaminuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(610114, 'HP:0100320', 'Rosenthal fibers', 'MP:0020140', 'increased brain external capsule size', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610115, 'HP:0100320', 'Rosenthal fibers', 'MP:0012092', 'diencephalon hypoplasia', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(610116, 'HP:0100320', 'Rosenthal fibers', 'MP:0012138', 'decreased forebrain size', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(610117, 'HP:0100320', 'Rosenthal fibers', 'MP:0030014', 'calcified brain', 0.4473684210526316, 6.213399309526074, 1.6672368273500293, 'UPHENO:0076805', 'abnormal brain morphology'),
(610118, 'HP:0100320', 'Rosenthal fibers', 'MP:0000783', 'abnormal forebrain morphology', 0.4166666666666667, 7.13344151829186, 1.724026478708571, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(610119, 'HP:0100320', 'Rosenthal fibers', 'MP:0020525', 'abnormal thalamus size', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(610120, 'HP:0100320', 'Rosenthal fibers', 'MP:0012775', 'abnormal brain weight', 0.4146341463414634, 6.213399309526074, 1.605081779406888, 'UPHENO:0076805', 'abnormal brain morphology'),
(610121, 'HP:0100320', 'Rosenthal fibers', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.40540540540540543, 7.13344151829186, 1.7005692431238613, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(610122, 'HP:0100320', 'Rosenthal fibers', 'MP:0000789', 'thickened cerebral cortex', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610123, 'HP:0100320', 'Rosenthal fibers', 'MP:0012262', 'abnormal hindbrain size', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(610124, 'HP:0100320', 'Rosenthal fibers', 'MP:0004101', 'abnormal brain interneuron morphology', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(610125, 'HP:0100320', 'Rosenthal fibers', 'MP:0020141', 'decreased brain external capsule size', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610126, 'HP:0100320', 'Rosenthal fibers', 'MP:0000831', 'diencephalon hyperplasia', 0.4222222222222222, 7.13344151829186, 1.7354819301696724, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(610127, 'HP:0100320', 'Rosenthal fibers', 'MP:0000791', 'delaminated cerebral cortex', 0.45454545454545453, 8.100674382308824, 1.918886322644279, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610128, 'HP:0100320', 'Rosenthal fibers', 'MP:0010058', 'enlarged olfactory bulb', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610129, 'HP:0100320', 'Rosenthal fibers', 'MP:0012137', 'abnormal forebrain size', 0.4878048780487805, 9.371930806217245, 2.1381472269253146, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(610130, 'HP:0100320', 'Rosenthal fibers', 'MP:0013229', 'abnormal brain ventricle size', 0.42857142857142855, 6.72807461644252, 1.698075543049819, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(610131, 'HP:0100320', 'Rosenthal fibers', 'MP:0011854', 'cerebral edema', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(610132, 'HP:0100320', 'Rosenthal fibers', 'MP:0000774', 'decreased brain size', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(610133, 'HP:0100320', 'Rosenthal fibers', 'MP:0002741', 'small olfactory bulb', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610134, 'HP:0100320', 'Rosenthal fibers', 'MP:0012468', 'decreased striatum size', 0.4166666666666667, 8.100674382308824, 1.8371937820025075, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610135, 'HP:0100320', 'Rosenthal fibers', 'MP:0000787', 'abnormal telencephalon morphology', 0.43243243243243246, 8.100674382308824, 1.8716287899807742, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610136, 'HP:0100320', 'Rosenthal fibers', 'MP:0000771', 'abnormal brain size', 0.4473684210526316, 6.213399309526074, 1.6672368273500293, 'UPHENO:0076805', 'abnormal brain morphology'),
(610137, 'HP:0100320', 'Rosenthal fibers', 'MP:0020066', 'abnormal neocortex size', 0.43478260869565216, 8.100674382308824, 1.876707846238799, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610138, 'HP:0100320', 'Rosenthal fibers', 'MP:0008540', 'abnormal cerebral hemisphere morphology', 0.41025641025641024, 8.100674382308824, 1.823006745117001, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610139, 'HP:0100320', 'Rosenthal fibers', 'MP:0012088', 'abnormal midbrain size', 0.4090909090909091, 6.72807461644252, 1.6590341049152486, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(610140, 'HP:0100320', 'Rosenthal fibers', 'MP:0012139', 'increased forebrain size', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(610141, 'HP:0100320', 'Rosenthal fibers', 'MP:0006254', 'thin cerebral cortex', 0.40816326530612246, 8.100674382308824, 1.8183502707302646, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610142, 'HP:0100320', 'Rosenthal fibers', 'MP:0000785', 'telencephalon hypoplasia', 0.43478260869565216, 8.100674382308824, 1.876707846238799, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610143, 'HP:0100320', 'Rosenthal fibers', 'MP:0020530', 'disorganized thalamus', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(610144, 'HP:0100320', 'Rosenthal fibers', 'MP:0012467', 'increased striatum size', 0.4166666666666667, 8.100674382308824, 1.8371937820025075, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610145, 'HP:0100320', 'Rosenthal fibers', 'MP:0005238', 'increased brain size', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(610146, 'HP:0100320', 'Rosenthal fibers', 'MP:0020569', 'abnormal premotor cortex size', 0.43478260869565216, 8.100674382308824, 1.876707846238799, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(610147, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0002177', 'abnormal outer ear morphology', 0.4186046511627907, 10.255471829629862, 2.0719527522972223, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610148, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0003713', 'abnormal ear rotation', 0.4117647058823529, 10.255471829629862, 2.0549553137750456, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610149, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0000020', 'scaly ears', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610150, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0000018', 'small ears', 0.4375, 10.255471829629862, 2.118199453654699, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610151, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0000017', 'big ears', 0.4375, 10.255471829629862, 2.118199453654699, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610152, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0000022', 'abnormal ear shape', 0.4375, 10.255471829629862, 2.118199453654699, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610153, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0003737', 'ossification of pinnae', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610154, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0006033', 'abnormal external auditory canal morphology', 0.45454545454545453, 14.285219173023913, 2.5481917985668967, 'UPHENO:0087920', 'abnormal external acoustic meatus morphology'),
(610155, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0030419', 'excessive cerumen', 0.42, 14.285219173023913, 2.4494472953444095, 'UPHENO:0087920', 'abnormal external acoustic meatus morphology'),
(610156, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0020290', 'floppy ears', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610157, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0003715', 'posteriorly rotated ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610158, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0003716', 'anteriorly rotated ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610159, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0000053', 'excessive ear growth', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610160, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0000023', 'abnormal ear position', 0.40425531914893614, 10.255471829629862, 2.036130898913413, 'UPHENO:0086699', 'abnormal external ear morphology'),
(610161, 'HP:0000413', 'Atresia of the external auditory canal', 'MP:0031285', 'external auditory canal stenosis', 0.425531914893617, 14.285219173023913, 2.4655256375409844, 'UPHENO:0087920', 'abnormal external acoustic meatus morphology'),
(610162, 'HP:0000232', 'Everted lower lip vermilion', 'MP:0003773', 'eclabion', 0.46551724137931033, 15.607147267911275, 2.6954398791215315, 'UPHENO:0080243', 'everted lip'),
(610163, 'HP:0001623', 'Breech presentation', 'MP:0013125', 'thorax swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610164, 'HP:0001623', 'Breech presentation', 'MP:0002113', 'abnormal skeleton development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610165, 'HP:0001623', 'Breech presentation', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610166, 'HP:0001623', 'Breech presentation', 'MP:0013124', 'mouth swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610167, 'HP:0001623', 'Breech presentation', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610168, 'HP:0001623', 'Breech presentation', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610169, 'HP:0001623', 'Breech presentation', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610170, 'HP:0001623', 'Breech presentation', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610171, 'HP:0001623', 'Breech presentation', 'MP:0000462', 'abnormal digestive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610172, 'HP:0001623', 'Breech presentation', 'MP:0002210', 'abnormal sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610173, 'HP:0001623', 'Breech presentation', 'MP:0020981', 'abnormal immune system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610174, 'HP:0001623', 'Breech presentation', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610175, 'HP:0001623', 'Breech presentation', 'MP:0014062', 'nervous system inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610176, 'HP:0001623', 'Breech presentation', 'MP:0013121', 'testicular swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610177, 'HP:0001623', 'Breech presentation', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610178, 'HP:0001623', 'Breech presentation', 'MP:0011167', 'abnormal adipose tissue development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610179, 'HP:0001623', 'Breech presentation', 'MP:0011174', 'lipodystrophy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610180, 'HP:0001623', 'Breech presentation', 'MP:0002132', 'abnormal respiratory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610181, 'HP:0001623', 'Breech presentation', 'MP:0001929', 'abnormal gametogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610182, 'HP:0001623', 'Breech presentation', 'MP:0013332', 'peliosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610183, 'HP:0001623', 'Breech presentation', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610184, 'HP:0001623', 'Breech presentation', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610185, 'HP:0001623', 'Breech presentation', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610186, 'HP:0001623', 'Breech presentation', 'MP:0006279', 'abnormal limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610187, 'HP:0001623', 'Breech presentation', 'MP:0003300', 'gastrointestinal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610188, 'HP:0001623', 'Breech presentation', 'MP:0014134', 'abnormal embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610189, 'HP:0001623', 'Breech presentation', 'MP:0005499', 'abnormal olfactory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610190, 'HP:0001623', 'Breech presentation', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610191, 'HP:0001623', 'Breech presentation', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610192, 'HP:0001623', 'Breech presentation', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610193, 'HP:0001623', 'Breech presentation', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610194, 'HP:0001623', 'Breech presentation', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610195, 'HP:0001623', 'Breech presentation', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610196, 'HP:0001623', 'Breech presentation', 'MP:0012514', 'pectus excavatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610197, 'HP:0001623', 'Breech presentation', 'MP:0004134', 'abnormal chest morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610198, 'HP:0001623', 'Breech presentation', 'MP:0001983', 'abnormal olfactory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610199, 'HP:0001623', 'Breech presentation', 'MP:0002164', 'abnormal gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610200, 'HP:0001623', 'Breech presentation', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610201, 'HP:0001623', 'Breech presentation', 'MP:0010478', 'intracranial aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610202, 'HP:0001623', 'Breech presentation', 'MP:0031277', 'pectus carinatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610203, 'HP:0001623', 'Breech presentation', 'MP:0000266', 'abnormal heart morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610204, 'HP:0001623', 'Breech presentation', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610205, 'HP:0001623', 'Breech presentation', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610206, 'HP:0001623', 'Breech presentation', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610207, 'HP:0001623', 'Breech presentation', 'MP:0013119', 'abdomen swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610208, 'HP:0001623', 'Breech presentation', 'MP:0000752', 'dystrophic muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610209, 'HP:0001623', 'Breech presentation', 'MP:0003385', 'abnormal body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610210, 'HP:0001623', 'Breech presentation', 'MP:0003936', 'abnormal reproductive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610211, 'HP:0001623', 'Breech presentation', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610212, 'HP:0001623', 'Breech presentation', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610213, 'HP:0001623', 'Breech presentation', 'MP:0010233', 'hairless tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610214, 'HP:0001623', 'Breech presentation', 'MP:0020982', 'abnormal skin adnexa development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610215, 'HP:0001623', 'Breech presentation', 'MP:0012260', 'encephalomeningocele', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610216, 'HP:0001623', 'Breech presentation', 'MP:0030222', 'hyperostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610217, 'HP:0001623', 'Breech presentation', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610218, 'HP:0001623', 'Breech presentation', 'MP:0005508', 'abnormal skeleton morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610219, 'HP:0001623', 'Breech presentation', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610220, 'HP:0001623', 'Breech presentation', 'MP:0003795', 'abnormal bone structure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610221, 'HP:0001623', 'Breech presentation', 'MP:0003942', 'abnormal urinary system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610222, 'HP:0001623', 'Breech presentation', 'MP:0000733', 'abnormal muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610223, 'HP:0001623', 'Breech presentation', 'MP:0008923', 'thoracoschisis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610224, 'HP:0001623', 'Breech presentation', 'MP:0002160', 'abnormal reproductive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610225, 'HP:0001623', 'Breech presentation', 'MP:0010352', 'gastrointestinal tract polyps', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610226, 'HP:0001623', 'Breech presentation', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610227, 'HP:0001623', 'Breech presentation', 'MP:0013120', 'urogenital swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610228, 'HP:0001623', 'Breech presentation', 'MP:0003861', 'abnormal nervous system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610229, 'HP:0001623', 'Breech presentation', 'MP:0003119', 'abnormal digestive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610230, 'HP:0001623', 'Breech presentation', 'MP:0013133', 'pale limbs', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610231, 'HP:0001623', 'Breech presentation', 'MP:0002836', 'abnormal chorion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610232, 'HP:0001623', 'Breech presentation', 'MP:0006281', 'abnormal tail development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610233, 'HP:0001623', 'Breech presentation', 'MP:0013118', 'swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610234, 'HP:0001623', 'Breech presentation', 'MP:0020973', 'abnormal gland development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610235, 'HP:0001623', 'Breech presentation', 'MP:0031099', 'abnormal sputum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610236, 'HP:0001623', 'Breech presentation', 'MP:0002111', 'abnormal tail morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610237, 'HP:0001623', 'Breech presentation', 'MP:0000685', 'abnormal immune system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610238, 'HP:0001623', 'Breech presentation', 'MP:0005029', 'abnormal amnion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610239, 'HP:0001623', 'Breech presentation', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610240, 'HP:0001623', 'Breech presentation', 'MP:0002925', 'abnormal cardiovascular development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610241, 'HP:0001623', 'Breech presentation', 'MP:0003115', 'abnormal respiratory system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610242, 'HP:0001623', 'Breech presentation', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610243, 'HP:0001623', 'Breech presentation', 'MP:0013113', 'greasy tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610244, 'HP:0001623', 'Breech presentation', 'MP:0005360', 'urolithiasis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610245, 'HP:0001623', 'Breech presentation', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610246, 'HP:0001623', 'Breech presentation', 'MP:0013177', 'abnormal tail tip morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610247, 'HP:0001623', 'Breech presentation', 'MP:0001985', 'abnormal gustatory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610248, 'HP:0001623', 'Breech presentation', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610249, 'HP:0001623', 'Breech presentation', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610250, 'HP:0001623', 'Breech presentation', 'MP:0001726', 'abnormal allantois morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610251, 'HP:0001623', 'Breech presentation', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610252, 'HP:0001623', 'Breech presentation', 'MP:0031310', 'abnormal cyst', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610253, 'HP:0001623', 'Breech presentation', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610254, 'HP:0001623', 'Breech presentation', 'MP:0003279', 'aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610255, 'HP:0001623', 'Breech presentation', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610256, 'HP:0001623', 'Breech presentation', 'MP:0031377', 'ambiguous external genitalia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610257, 'HP:0001623', 'Breech presentation', 'MP:0013122', 'tail swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610258, 'HP:0001623', 'Breech presentation', 'MP:0003935', 'abnormal craniofacial development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610259, 'HP:0001623', 'Breech presentation', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610260, 'HP:0001623', 'Breech presentation', 'MP:0005500', 'abnormal gustatory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610261, 'HP:0001623', 'Breech presentation', 'MP:0013123', 'head/neck swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610262, 'HP:0001623', 'Breech presentation', 'MP:0013283', 'failure of ventral body wall closure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610263, 'HP:0001623', 'Breech presentation', 'MP:0002163', 'abnormal gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610264, 'HP:0001623', 'Breech presentation', 'MP:0013126', 'teat swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(610265, 'HP:0012206', 'Abnormal sperm motility', 'MP:0014190', 'abnormal epididymis physiology', 0.40476190476190477, 11.073168695908924, 2.117072708507196, 'UPHENO:0002371', 'abnormality of male reproductive system physiology'),
(610266, 'HP:0001691', 'Muscular subvalvular aortic stenosis', 'MP:0010577', 'abnormal heart right ventricle size', 0.4222222222222222, 10.533898285880637, 2.1089442721246523, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(610267, 'HP:0001691', 'Muscular subvalvular aortic stenosis', 'MP:0010578', 'abnormal heart left ventricle size', 0.4883720930232558, 13.237913458245556, 2.542641835348445, 'UPHENO:0019891', 'abnormal heart left ventricle morphology'),
(610268, 'HP:0001691', 'Muscular subvalvular aortic stenosis', 'MP:0020204', 'abnormal heart left ventricle weight', 0.42, 13.237913458245556, 2.357949035170848, 'UPHENO:0019891', 'abnormal heart left ventricle morphology'),
(610269, 'HP:0001691', 'Muscular subvalvular aortic stenosis', 'MP:0005648', 'heart right ventricle degeneration', 0.41304347826086957, 10.533898285880637, 2.08589500877833, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(610270, 'HP:0001691', 'Muscular subvalvular aortic stenosis', 'MP:0010579', 'increased heart left ventricle size', 0.4117647058823529, 13.237913458245556, 2.334717443638635, 'UPHENO:0019891', 'abnormal heart left ventricle morphology'),
(610271, 'HP:0001691', 'Muscular subvalvular aortic stenosis', 'MP:0010580', 'decreased heart left ventricle size', 0.44680851063829785, 13.237913458245556, 2.4320387324706356, 'UPHENO:0019891', 'abnormal heart left ventricle morphology'),
(610272, 'HP:0001691', 'Muscular subvalvular aortic stenosis', 'MP:0008772', 'increased heart ventricle size', 0.41304347826086957, 10.533898285880637, 2.08589500877833, 'UPHENO:0015282', 'abnormal cardiac ventricle morphology in the heart'),
(610273, 'HP:0004810', 'Congenital hypoplastic anemia', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.42105263157894735, 7.94655706237675, 1.8291852730398854, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(610274, 'HP:0004810', 'Congenital hypoplastic anemia', 'MP:0002447', 'abnormal erythrocyte morphology', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(610275, 'HP:0004810', 'Congenital hypoplastic anemia', 'MP:0000358', 'abnormal cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(610276, 'HP:0004810', 'Congenital hypoplastic anemia', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.43902439024390244, 10.15319077934013, 2.111278852006483, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(610277, 'HP:0004810', 'Congenital hypoplastic anemia', 'MP:0013658', 'abnormal myeloid cell morphology', 0.4358974358974359, 9.052558416233639, 1.9864508556589051, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(610278, 'HP:0004810', 'Congenital hypoplastic anemia', 'MP:0002424', 'abnormal reticulocyte morphology', 0.4186046511627907, 10.15319077934013, 2.0615947430023533, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(610279, 'HP:0011402', 'Demyelinating sensory neuropathy', 'MP:0013438', 'dysmyelination', 0.41025641025641024, 7.291997705654976, 1.7296209996181215, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610280, 'HP:0011402', 'Demyelinating sensory neuropathy', 'MP:0010050', 'hypermyelination', 0.41025641025641024, 7.291997705654976, 1.7296209996181215, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610281, 'HP:0011402', 'Demyelinating sensory neuropathy', 'MP:0000920', 'abnormal myelination', 0.42105263157894735, 7.291997705654976, 1.7522313841024746, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610282, 'HP:0011402', 'Demyelinating sensory neuropathy', 'MP:0000921', 'demyelination', 0.41025641025641024, 7.291997705654976, 1.7296209996181215, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(610283, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0004969', 'pale kidney', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610284, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 7.390401409715969, 1.7796951676841382, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610285, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610286, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0031002', 'abnormal kidney glycogen level', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610287, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011767', 'ureterocele', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610288, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610289, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0000534', 'abnormal ureter morphology', 0.41935483870967744, 7.390401409715969, 1.7604546546762325, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610290, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0012025', 'abnormal comma shaped body morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610291, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0002955', 'increased compensatory renal growth', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610292, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0002706', 'abnormal kidney size', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610293, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610294, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011402', 'renal cast', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610295, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0009860', 'nephrosclerosis', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610296, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0008528', 'polycystic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610297, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011534', 'granular kidney', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610298, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610299, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610300, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0003600', 'ectopic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610301, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0002135', 'abnormal kidney morphology', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610302, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0003197', 'nephrocalcinosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610303, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610304, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610305, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011379', 'abnormal kidney outer medulla outer stripe morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610306, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011378', 'abnormal kidney outer medulla inner stripe morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610307, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011334', 'abnormal nephrogenic zone morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610308, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0002703', 'abnormal renal tubule morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610309, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011364', 'abnormal metanephros morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610310, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0003985', 'renal fibrosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610311, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0004195', 'abnormal kidney calyx morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610312, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610313, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0005360', 'urolithiasis', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610314, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0003942', 'abnormal urinary system development', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610315, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0002956', 'decreased compensatory renal growth', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610316, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0012026', 'abnormal S-shaped body morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610317, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0003881', 'abnormal nephron morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610318, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011361', 'pelvic kidney', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610319, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610320, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011337', 'abnormal perihilar interstitium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610321, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610322, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0003613', 'abnormal kidney medulla development', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610323, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0004755', 'abnormal loop of Henle morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610324, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011383', 'abnormal kidney capsule morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610325, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610326, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610327, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610328, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0008487', 'abnormal mesonephros morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610329, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011382', 'abnormal kidney lobule morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610330, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0009641', 'kidney degeneration', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610331, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610332, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0011797', 'blind ureter', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610333, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0003675', 'kidney cyst', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610334, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0000527', 'abnormal kidney development', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610335, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610336, 'HP:0032641', 'Renal interstitial granulomas', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610337, 'HP:0033591', 'Staghorn calculus', 'MP:0005360', 'urolithiasis', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610338, 'HP:0033591', 'Staghorn calculus', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610339, 'HP:0033591', 'Staghorn calculus', 'MP:0011334', 'abnormal nephrogenic zone morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610340, 'HP:0033591', 'Staghorn calculus', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610341, 'HP:0033591', 'Staghorn calculus', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610342, 'HP:0033591', 'Staghorn calculus', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610343, 'HP:0033591', 'Staghorn calculus', 'MP:0012025', 'abnormal comma shaped body morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610344, 'HP:0033591', 'Staghorn calculus', 'MP:0002703', 'abnormal renal tubule morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610345, 'HP:0033591', 'Staghorn calculus', 'MP:0011402', 'renal cast', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610346, 'HP:0033591', 'Staghorn calculus', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610347, 'HP:0033591', 'Staghorn calculus', 'MP:0011534', 'granular kidney', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610348, 'HP:0033591', 'Staghorn calculus', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 7.390401409715969, 1.7796951676841382, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610349, 'HP:0033591', 'Staghorn calculus', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610350, 'HP:0033591', 'Staghorn calculus', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610351, 'HP:0033591', 'Staghorn calculus', 'MP:0004969', 'pale kidney', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610352, 'HP:0033591', 'Staghorn calculus', 'MP:0031002', 'abnormal kidney glycogen level', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610353, 'HP:0033591', 'Staghorn calculus', 'MP:0004195', 'abnormal kidney calyx morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610354, 'HP:0033591', 'Staghorn calculus', 'MP:0011378', 'abnormal kidney outer medulla inner stripe morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610355, 'HP:0033591', 'Staghorn calculus', 'MP:0011382', 'abnormal kidney lobule morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610356, 'HP:0033591', 'Staghorn calculus', 'MP:0008487', 'abnormal mesonephros morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610357, 'HP:0033591', 'Staghorn calculus', 'MP:0003942', 'abnormal urinary system development', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610358, 'HP:0033591', 'Staghorn calculus', 'MP:0012026', 'abnormal S-shaped body morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610359, 'HP:0033591', 'Staghorn calculus', 'MP:0002706', 'abnormal kidney size', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610360, 'HP:0033591', 'Staghorn calculus', 'MP:0003613', 'abnormal kidney medulla development', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610361, 'HP:0033591', 'Staghorn calculus', 'MP:0002135', 'abnormal kidney morphology', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610362, 'HP:0033591', 'Staghorn calculus', 'MP:0003197', 'nephrocalcinosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610363, 'HP:0033591', 'Staghorn calculus', 'MP:0011767', 'ureterocele', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610364, 'HP:0033591', 'Staghorn calculus', 'MP:0011364', 'abnormal metanephros morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610365, 'HP:0033591', 'Staghorn calculus', 'MP:0002956', 'decreased compensatory renal growth', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610366, 'HP:0033591', 'Staghorn calculus', 'MP:0002955', 'increased compensatory renal growth', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610367, 'HP:0033591', 'Staghorn calculus', 'MP:0009860', 'nephrosclerosis', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610368, 'HP:0033591', 'Staghorn calculus', 'MP:0003985', 'renal fibrosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610369, 'HP:0033591', 'Staghorn calculus', 'MP:0000527', 'abnormal kidney development', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610370, 'HP:0033591', 'Staghorn calculus', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610371, 'HP:0033591', 'Staghorn calculus', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610372, 'HP:0033591', 'Staghorn calculus', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610373, 'HP:0033591', 'Staghorn calculus', 'MP:0003600', 'ectopic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610374, 'HP:0033591', 'Staghorn calculus', 'MP:0004755', 'abnormal loop of Henle morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610375, 'HP:0033591', 'Staghorn calculus', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610376, 'HP:0033591', 'Staghorn calculus', 'MP:0011379', 'abnormal kidney outer medulla outer stripe morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610377, 'HP:0033591', 'Staghorn calculus', 'MP:0011361', 'pelvic kidney', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610378, 'HP:0033591', 'Staghorn calculus', 'MP:0000534', 'abnormal ureter morphology', 0.41935483870967744, 7.390401409715969, 1.7604546546762325, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610379, 'HP:0033591', 'Staghorn calculus', 'MP:0011797', 'blind ureter', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(610380, 'HP:0033591', 'Staghorn calculus', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610381, 'HP:0033591', 'Staghorn calculus', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610382, 'HP:0033591', 'Staghorn calculus', 'MP:0009641', 'kidney degeneration', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610383, 'HP:0033591', 'Staghorn calculus', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610384, 'HP:0033591', 'Staghorn calculus', 'MP:0011383', 'abnormal kidney capsule morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610385, 'HP:0033591', 'Staghorn calculus', 'MP:0003675', 'kidney cyst', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610386, 'HP:0033591', 'Staghorn calculus', 'MP:0011337', 'abnormal perihilar interstitium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610387, 'HP:0033591', 'Staghorn calculus', 'MP:0008528', 'polycystic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610388, 'HP:0033591', 'Staghorn calculus', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610389, 'HP:0033591', 'Staghorn calculus', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610390, 'HP:0033591', 'Staghorn calculus', 'MP:0003881', 'abnormal nephron morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(610391, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0013255', 'abnormal circulating thrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610392, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012328', 'decreased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610393, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610394, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610395, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0003349', 'abnormal circulating renin level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610396, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020246', 'abnormal circulating arginase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610397, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011891', 'decreased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610398, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610399, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012621', 'decreased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610400, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610401, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012619', 'increased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610402, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610403, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031075', 'abnormal circulating troponin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610404, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0001560', 'abnormal circulating insulin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610405, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012223', 'increased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610406, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011893', 'increased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610407, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610408, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012325', 'decreased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610409, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610410, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031076', 'decreased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610411, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0005667', 'abnormal circulating leptin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610412, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0008820', 'abnormal blood uric acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(610413, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610414, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031107', 'abnormal circulating myoglobin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610415, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011887', 'decreased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610416, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0009699', 'hyperchylomicronemia', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610417, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012329', 'increased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610418, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0008804', 'abnormal circulating amylase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610419, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011912', 'abnormal circulating fibronectin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610420, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610421, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0013256', 'increased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610422, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012616', 'increased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610423, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610424, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012622', 'increased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610425, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610426, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020257', 'increased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610427, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0004730', 'abnormal circulating gastrin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610428, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020985', 'increased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610429, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610430, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0005416', 'abnormal circulating protein level', 0.4444444444444444, 8.144985856518405, 1.9026281071213522, 'UPHENO:0046362', 'abnormal protein level'),
(610431, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011890', 'increased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610432, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012222', 'decreased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610433, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610434, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610435, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610436, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011885', 'abnormal circulating lipase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610437, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610438, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031083', 'increased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610439, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031079', 'increased circulating troponin I level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610440, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610441, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011894', 'decreased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610442, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610443, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610444, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610445, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610446, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020248', 'decreased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610447, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011889', 'abnormal circulating ferritin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610448, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610449, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610450, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610451, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020247', 'increased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610452, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012615', 'decreased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610453, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020983', 'abnormal circulating factor XI level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610454, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020256', 'abnormal circulating factor XII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610455, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610456, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(610457, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0002695', 'abnormal circulating glucagon level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610458, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0013257', 'decreased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610459, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012618', 'decreased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610460, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610461, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610462, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610463, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011888', 'abnormal circulating total protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610464, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012333', 'increased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610465, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610466, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610467, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012614', 'abnormal circulating factor IX level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610468, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610469, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031108', 'increased circulating myoglobin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610470, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610471, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610472, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012666', 'increased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610473, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031078', 'increased circulating troponin T level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610474, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610475, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011892', 'abnormal circulating transferrin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610476, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012327', 'abnormal circulating factor VIII level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610477, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020255', 'absent circulating factor XII protein', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610478, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610479, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0002941', 'increased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610480, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0005419', 'decreased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610481, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0008806', 'increased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610482, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012617', 'abnormal circulating factor X level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610483, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0011886', 'increased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610484, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012324', 'abnormal circulating antithrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610485, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4074074074074074, 8.670509328908704, 1.8794759180666387, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610486, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610487, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031081', 'abnormal circulating D-dimer level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610488, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020258', 'decreased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610489, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031082', 'decreased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610490, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0020984', 'decreased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610491, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012332', 'decreased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610492, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0008805', 'decreased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610493, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0001570', 'abnormal circulating enzyme level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610494, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0002965', 'increased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610495, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012221', 'abnormal circulating prothrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610496, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0012326', 'increased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610497, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031065', 'increased circulating procalcitonin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610498, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610499, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610500, 'HP:0030130', 'Impaired von Willebrand factor collagen binding activity', 'MP:0031077', 'increased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610501, 'HP:0031880', 'Eyelid laxity', 'MP:0004021', 'abnormal rod electrophysiology', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610502, 'HP:0031880', 'Eyelid laxity', 'MP:0012033', 'abnormal ERG implicit time', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610503, 'HP:0031880', 'Eyelid laxity', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610504, 'HP:0031880', 'Eyelid laxity', 'MP:0006148', 'binocular blindness', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(610505, 'HP:0031880', 'Eyelid laxity', 'MP:0006190', 'retina ischemia', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610506, 'HP:0031880', 'Eyelid laxity', 'MP:0012035', 'abnormal b-wave shape', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610507, 'HP:0031880', 'Eyelid laxity', 'MP:0003878', 'abnormal ear physiology', 0.4117647058823529, 5.059610039003922, 1.4433879726497136, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610508, 'HP:0031880', 'Eyelid laxity', 'MP:0013145', 'eye discharge', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610509, 'HP:0031880', 'Eyelid laxity', 'MP:0012039', 'abnormal b-wave implicit time', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610510, 'HP:0031880', 'Eyelid laxity', 'MP:0012149', 'decreased b-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610511, 'HP:0031880', 'Eyelid laxity', 'MP:0006152', 'tunnel vision', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610512, 'HP:0031880', 'Eyelid laxity', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4857142857142857, 9.175301480945878, 2.1110601613954194, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(610513, 'HP:0031880', 'Eyelid laxity', 'MP:0011275', 'abnormal behavioral response to light', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(610514, 'HP:0031880', 'Eyelid laxity', 'MP:0012036', 'abnormal a-wave latency', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610515, 'HP:0031880', 'Eyelid laxity', 'MP:0012153', 'increased b-wave latency', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610516, 'HP:0031880', 'Eyelid laxity', 'MP:0002001', 'blindness', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610517, 'HP:0031880', 'Eyelid laxity', 'MP:0020963', 'decreased c-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610518, 'HP:0031880', 'Eyelid laxity', 'MP:0012040', 'abnormal c-wave shape', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610519, 'HP:0031880', 'Eyelid laxity', 'MP:0006149', 'decreased visual acuity', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610520, 'HP:0031880', 'Eyelid laxity', 'MP:0004022', 'abnormal cone electrophysiology', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610521, 'HP:0031880', 'Eyelid laxity', 'MP:0006150', 'double vision', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610522, 'HP:0031880', 'Eyelid laxity', 'MP:0006147', 'monocular blindness', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(610523, 'HP:0031880', 'Eyelid laxity', 'MP:0001999', 'photosensitivity', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610524, 'HP:0031880', 'Eyelid laxity', 'MP:0012037', 'abnormal b-wave latency', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610525, 'HP:0031880', 'Eyelid laxity', 'MP:0020980', 'increased FO-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610526, 'HP:0031880', 'Eyelid laxity', 'MP:0013476', 'abnormal Harderian gland porphyrin secretion', 0.425, 9.175301480945878, 1.9747159617023402, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(610527, 'HP:0031880', 'Eyelid laxity', 'MP:0012146', 'increased b-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610528, 'HP:0031880', 'Eyelid laxity', 'MP:0014157', 'alacrima', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610529, 'HP:0031880', 'Eyelid laxity', 'MP:0012143', 'decreased a-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610530, 'HP:0031880', 'Eyelid laxity', 'MP:0020439', 'absent b-wave', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610531, 'HP:0031880', 'Eyelid laxity', 'MP:0020219', 'increased tear production', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610532, 'HP:0031880', 'Eyelid laxity', 'MP:0012150', 'increased b-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610533, 'HP:0031880', 'Eyelid laxity', 'MP:0006224', 'oculomotor apraxia', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(610534, 'HP:0031880', 'Eyelid laxity', 'MP:0006153', 'hypermetropia', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610535, 'HP:0031880', 'Eyelid laxity', 'MP:0005260', 'ocular hypotension', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610536, 'HP:0031880', 'Eyelid laxity', 'MP:0020958', 'abnormal c-wave implicit time', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610537, 'HP:0031880', 'Eyelid laxity', 'MP:0012034', 'abnormal a-wave shape', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610538, 'HP:0031880', 'Eyelid laxity', 'MP:0006251', 'eyelid apraxia', 0.4722222222222222, 13.944182255188847, 2.5660773042948173, 'UPHENO:0078742', 'abnormality of eyelid physiology'),
(610539, 'HP:0031880', 'Eyelid laxity', 'MP:0012154', 'decreased b-wave latency', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610540, 'HP:0031880', 'Eyelid laxity', 'MP:0012032', 'abnormal ERG latency', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610541, 'HP:0031880', 'Eyelid laxity', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(610542, 'HP:0031880', 'Eyelid laxity', 'MP:0012147', 'increased a-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610543, 'HP:0031880', 'Eyelid laxity', 'MP:0008144', 'nyctalopia', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(610544, 'HP:0031880', 'Eyelid laxity', 'MP:0010749', 'absent visual evoked potential', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610545, 'HP:0031880', 'Eyelid laxity', 'MP:0008145', 'hemeralopia', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610546, 'HP:0031880', 'Eyelid laxity', 'MP:0001348', 'abnormal lacrimal gland physiology', 0.40476190476190477, 9.175301480945878, 1.9271254510779465, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(610547, 'HP:0031880', 'Eyelid laxity', 'MP:0012144', 'decreased b-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610548, 'HP:0031880', 'Eyelid laxity', 'MP:0020976', 'increased FO-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610549, 'HP:0031880', 'Eyelid laxity', 'MP:0003100', 'myopia', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610550, 'HP:0031880', 'Eyelid laxity', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610551, 'HP:0031880', 'Eyelid laxity', 'MP:0014179', 'abnormal blood-retina barrier function', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(610552, 'HP:0031880', 'Eyelid laxity', 'MP:0002090', 'abnormal vision', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610553, 'HP:0031880', 'Eyelid laxity', 'MP:0012038', 'abnormal a-wave implicit time', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610554, 'HP:0031880', 'Eyelid laxity', 'MP:0012152', 'decreased a-wave latency', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610555, 'HP:0031880', 'Eyelid laxity', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610556, 'HP:0031880', 'Eyelid laxity', 'MP:0020960', 'increased c-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610557, 'HP:0031880', 'Eyelid laxity', 'MP:0005257', 'abnormal intraocular pressure', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610558, 'HP:0031880', 'Eyelid laxity', 'MP:0020979', 'decreased FO-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610559, 'HP:0031880', 'Eyelid laxity', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610560, 'HP:0031880', 'Eyelid laxity', 'MP:0020220', 'decreased tear production', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610561, 'HP:0031880', 'Eyelid laxity', 'MP:0020977', 'decreased FO-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610562, 'HP:0031880', 'Eyelid laxity', 'MP:0012031', 'abnormal b-wave amplitude', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610563, 'HP:0031880', 'Eyelid laxity', 'MP:0020961', 'abnormal c-wave amplitude', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610564, 'HP:0031880', 'Eyelid laxity', 'MP:0003011', 'delayed dark adaptation', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610565, 'HP:0031880', 'Eyelid laxity', 'MP:0014132', 'abnormal tear film physiology', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610566, 'HP:0031880', 'Eyelid laxity', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610567, 'HP:0031880', 'Eyelid laxity', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610568, 'HP:0031880', 'Eyelid laxity', 'MP:0005253', 'abnormal eye physiology', 0.48484848484848486, 5.772412880326452, 1.6729451990266024, 'UPHENO:0075997', 'abnormal orbital region'),
(610569, 'HP:0031880', 'Eyelid laxity', 'MP:0020959', 'decreased c-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610570, 'HP:0031880', 'Eyelid laxity', 'MP:0020218', 'abnormal tear production', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610571, 'HP:0031880', 'Eyelid laxity', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(610572, 'HP:0031880', 'Eyelid laxity', 'MP:0003101', 'high myopia', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610573, 'HP:0031880', 'Eyelid laxity', 'MP:0001389', 'abnormal eye movement', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(610574, 'HP:0031880', 'Eyelid laxity', 'MP:0003859', 'abnormal Harderian gland physiology', 0.4358974358974359, 9.175301480945878, 1.999872593224442, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(610575, 'HP:0031880', 'Eyelid laxity', 'MP:0012148', 'decreased a-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610576, 'HP:0031880', 'Eyelid laxity', 'MP:0020962', 'increased c-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610577, 'HP:0031880', 'Eyelid laxity', 'MP:0003096', 'increased corneal light-scattering', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610578, 'HP:0031880', 'Eyelid laxity', 'MP:0012145', 'increased a-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610579, 'HP:0031880', 'Eyelid laxity', 'MP:0020974', 'abnormal FO-wave shape', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610580, 'HP:0031880', 'Eyelid laxity', 'MP:0001337', 'dry eyes', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610581, 'HP:0031880', 'Eyelid laxity', 'MP:0030144', 'abnormal facial muscle physiology', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(610582, 'HP:0031880', 'Eyelid laxity', 'MP:0010748', 'abnormal visual evoked potential', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610583, 'HP:0031880', 'Eyelid laxity', 'MP:0012030', 'abnormal a-wave amplitude', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610584, 'HP:0031880', 'Eyelid laxity', 'MP:0020860', 'abnormal cornea physiology', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610585, 'HP:0031880', 'Eyelid laxity', 'MP:0006145', 'legal blindness', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(610586, 'HP:0031880', 'Eyelid laxity', 'MP:0013468', 'chromodacryorrhea', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610587, 'HP:0031880', 'Eyelid laxity', 'MP:0012151', 'increased a-wave latency', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(610588, 'HP:0031880', 'Eyelid laxity', 'MP:0005258', 'ocular hypertension', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610589, 'HP:0031880', 'Eyelid laxity', 'MP:0031497', 'increased visual acuity', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(610590, 'HP:0031880', 'Eyelid laxity', 'MP:0011832', 'abnormal visual acuity', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(610591, 'HP:0031880', 'Eyelid laxity', 'MP:0005551', 'abnormal eye electrophysiology', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(610592, 'HP:0007373', 'Motor neuron atrophy', 'MP:0020435', 'decreased astrocyte size', 0.4482758620689655, 10.08882196022041, 2.1266347503692575, 'UPHENO:0080059', 'decreased size of the cell'),
(610593, 'HP:0007373', 'Motor neuron atrophy', 'MP:0009269', 'decreased fat cell size', 0.4528301886792453, 10.08882196022041, 2.137410384506897, 'UPHENO:0080059', 'decreased size of the cell'),
(610594, 'HP:0007373', 'Motor neuron atrophy', 'MP:0005603', 'neuron hypertrophy', 0.42592592592592593, 9.126020578174659, 1.9715498382688923, 'UPHENO:0084885', 'abnormal neuron morphology'),
(610595, 'HP:0200025', 'Mandibular pain', 'MP:0004592', 'small mandible', 0.4025974025974026, 11.410750055107773, 2.1433474599034468, 'UPHENO:0083646', 'abnormal mandible morphology'),
(610596, 'HP:0200025', 'Mandibular pain', 'MP:0030050', 'large mandible', 0.4025974025974026, 11.410750055107773, 2.1433474599034468, 'UPHENO:0083646', 'abnormal mandible morphology'),
(610597, 'HP:0003909', 'Cortical subperiosteal resorption of humeral metaphyses', 'MP:0004351', 'short humerus', 0.4125, 11.214829845132515, 2.1508410706319427, 'UPHENO:0087565', 'abnormal humerus morphology'),
(610598, 'HP:0003909', 'Cortical subperiosteal resorption of humeral metaphyses', 'MP:0004350', 'long humerus', 0.4177215189873418, 11.214829845132515, 2.164411180458401, 'UPHENO:0087565', 'abnormal humerus morphology'),
(610599, 'HP:0032331', 'Increased urinary 11-deoxytetrahydrocorticosterone level', 'MP:0000679', 'increased percent water in carcass', 0.40625, 6.266926249198224, 1.59559982098795, 'UPHENO:0051763', 'abnormal multicellular organism chemical entity level'),
(610600, 'HP:0032331', 'Increased urinary 11-deoxytetrahydrocorticosterone level', 'MP:0000676', 'abnormal body water content', 0.41935483870967744, 6.266926249198224, 1.621131039255607, 'UPHENO:0051763', 'abnormal multicellular organism chemical entity level'),
(610601, 'HP:0032331', 'Increased urinary 11-deoxytetrahydrocorticosterone level', 'MP:0000683', 'decreased percent water in carcass', 0.40625, 6.266926249198224, 1.59559982098795, 'UPHENO:0051763', 'abnormal multicellular organism chemical entity level'),
(610602, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610603, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610604, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610605, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610606, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0013255', 'abnormal circulating thrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610607, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0002965', 'increased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610608, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0003349', 'abnormal circulating renin level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610609, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020255', 'absent circulating factor XII protein', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610610, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610611, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031076', 'decreased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610612, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012328', 'decreased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610613, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020983', 'abnormal circulating factor XI level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610614, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610615, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012221', 'abnormal circulating prothrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610616, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020248', 'decreased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610617, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0005419', 'decreased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610618, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031077', 'increased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610619, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012614', 'abnormal circulating factor IX level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610620, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011890', 'increased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610621, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0013256', 'increased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610622, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0002695', 'abnormal circulating glucagon level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610623, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610624, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610625, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610626, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610627, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031081', 'abnormal circulating D-dimer level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610628, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012666', 'increased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610629, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610630, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610631, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012617', 'abnormal circulating factor X level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610632, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610633, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011887', 'decreased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610634, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012616', 'increased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610635, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0005667', 'abnormal circulating leptin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610636, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0008820', 'abnormal blood uric acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(610637, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0005416', 'abnormal circulating protein level', 0.4444444444444444, 8.144985856518405, 1.9026281071213522, 'UPHENO:0046362', 'abnormal protein level'),
(610638, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020985', 'increased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610639, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031108', 'increased circulating myoglobin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610640, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020246', 'abnormal circulating arginase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610641, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0008805', 'decreased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610642, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012223', 'increased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610643, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011892', 'abnormal circulating transferrin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610644, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012327', 'abnormal circulating factor VIII level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610645, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031107', 'abnormal circulating myoglobin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610646, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4074074074074074, 8.670509328908704, 1.8794759180666387, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610647, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0008806', 'increased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610648, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012325', 'decreased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610649, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(610650, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610651, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011885', 'abnormal circulating lipase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610652, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610653, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012622', 'increased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610654, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011889', 'abnormal circulating ferritin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610655, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0001560', 'abnormal circulating insulin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610656, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610657, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012222', 'decreased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610658, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610659, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610660, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610661, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020984', 'decreased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610662, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610663, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610664, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011888', 'abnormal circulating total protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610665, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031079', 'increased circulating troponin I level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610666, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610667, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0004730', 'abnormal circulating gastrin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610668, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031078', 'increased circulating troponin T level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610669, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610670, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031075', 'abnormal circulating troponin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610671, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020257', 'increased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610672, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0008804', 'abnormal circulating amylase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610673, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011893', 'increased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610674, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610675, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020256', 'abnormal circulating factor XII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610676, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011891', 'decreased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610677, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0009699', 'hyperchylomicronemia', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610678, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031065', 'increased circulating procalcitonin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610679, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012615', 'decreased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610680, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0013257', 'decreased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610681, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610682, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610683, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012332', 'decreased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610684, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012333', 'increased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610685, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610686, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610687, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012329', 'increased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610688, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020247', 'increased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610689, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610690, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610691, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012619', 'increased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610692, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012621', 'decreased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610693, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031082', 'decreased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610694, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011886', 'increased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610695, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610696, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012324', 'abnormal circulating antithrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610697, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(610698, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610699, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031083', 'increased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610700, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012618', 'decreased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610701, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0001570', 'abnormal circulating enzyme level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610702, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610703, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011894', 'decreased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610704, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610705, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610706, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0020258', 'decreased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(610707, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0002941', 'increased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610708, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0011912', 'abnormal circulating fibronectin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(610709, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610710, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0012326', 'increased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(610711, 'HP:0030129', 'Impaired ristocetin cofactor assay activity', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(610712, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610713, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0004134', 'abnormal chest morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610714, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0005500', 'abnormal gustatory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610715, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0003385', 'abnormal body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610716, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0003397', 'increased muscle weight', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610717, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002109', 'abnormal limb morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610718, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610719, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0005499', 'abnormal olfactory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610720, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610721, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0003632', 'abnormal nervous system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610722, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002111', 'abnormal tail morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610723, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0013857', 'abnormal abdominal muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610724, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610725, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0004818', 'increased skeletal muscle mass', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610726, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610727, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610728, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000752', 'dystrophic muscle', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610729, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0003199', 'calcified muscle', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610730, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610731, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0013118', 'swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610732, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002925', 'abnormal cardiovascular development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610733, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610734, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0010290', 'increased muscle tumor incidence', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610735, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0013113', 'greasy tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610736, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610737, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0005508', 'abnormal skeleton morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610738, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610739, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0010233', 'hairless tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610740, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000731', 'increased collagen deposition in the muscles', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610741, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610742, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610743, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0020973', 'abnormal gland development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610744, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0012413', 'decreased muscle tumor incidence', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610745, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0003939', 'abnormal myotome morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610746, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0008923', 'thoracoschisis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610747, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002108', 'abnormal muscle morphology', 0.5454545454545454, 7.206267831629091, 1.9825971715214765, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610748, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000767', 'abnormal smooth muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610749, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610750, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610751, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000733', 'abnormal muscle development', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610752, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0005503', 'abnormal tendon morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610753, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0010678', 'abnormal skin adnexa morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610754, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0004233', 'abnormal muscle weight', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610755, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0004819', 'decreased skeletal muscle mass', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610756, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002163', 'abnormal gland morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610757, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0013332', 'peliosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610758, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0020982', 'abnormal skin adnexa development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610759, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610760, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610761, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0010630', 'abnormal cardiac muscle tissue morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610762, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000736', 'delayed muscle development', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610763, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0009407', 'increased skeletal muscle fiber density', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610764, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000749', 'muscle degeneration', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610765, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610766, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610767, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0002160', 'abnormal reproductive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610768, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610769, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0000428', 'abnormal craniofacial morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610770, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610771, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0004817', 'abnormal skeletal muscle mass', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610772, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610773, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0031112', 'rhabdomyolysis', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(610774, 'HP:0410169', 'Abnormal morphology of the shoulder musculature', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(610775, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610776, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610777, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610778, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610779, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610780, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610781, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610782, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610783, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610784, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610785, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610786, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610787, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610788, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610789, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610790, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610791, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610792, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610793, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610794, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610795, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610796, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610797, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610798, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610799, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610800, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610801, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610802, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610803, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610804, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610805, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610806, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610807, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610808, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610809, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610810, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610811, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610812, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610813, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610814, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610815, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610816, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610817, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610818, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610819, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610820, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610821, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610822, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610823, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610824, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610825, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610826, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610827, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610828, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610829, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610830, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610831, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610832, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610833, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610834, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610835, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610836, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610837, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610838, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610839, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610840, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610841, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610842, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610843, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610844, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610845, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610846, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610847, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610848, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610849, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610850, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610851, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610852, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610853, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610854, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610855, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610856, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610857, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610858, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610859, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610860, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610861, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610862, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610863, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610864, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610865, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610866, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610867, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610868, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610869, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610870, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610871, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031066', 'cytokine storm', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610872, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610873, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031053', 'pleuritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610874, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610875, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610876, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610877, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610878, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610879, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610880, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610881, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610882, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610883, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610884, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610885, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610886, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610887, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610888, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610889, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610890, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610891, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610892, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610893, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610894, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610895, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610896, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610897, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610898, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610899, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610900, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610901, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610902, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610903, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610904, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610905, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610906, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610907, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610908, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610909, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610910, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610911, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610912, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610913, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610914, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610915, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610916, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610917, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610918, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610919, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610920, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610921, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610922, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610923, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610924, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610925, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610926, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610927, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610928, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610929, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610930, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610931, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610932, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610933, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610934, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610935, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610936, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610937, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610938, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610939, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610940, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610941, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610942, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610943, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610944, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610945, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610946, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610947, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610948, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610949, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610950, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610951, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610952, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610953, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610954, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610955, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610956, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610957, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610958, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610959, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610960, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610961, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610962, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610963, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610964, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610965, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610966, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610967, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610968, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610969, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610970, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610971, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610972, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610973, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610974, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610975, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610976, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610977, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610978, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610979, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610980, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610981, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610982, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610983, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610984, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610985, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610986, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610987, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610988, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610989, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610990, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610991, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610992, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610993, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610994, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610995, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610996, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610997, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(610998, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(610999, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611000, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611001, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611002, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611003, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611004, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611005, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611006, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611007, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611008, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611009, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611010, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611011, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611012, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611013, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611014, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611015, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611016, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611017, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611018, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611019, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611020, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611021, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611022, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611023, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611024, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611025, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611026, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611027, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611028, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611029, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611030, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611031, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611032, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611033, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611034, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611035, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003777', 'lip inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611036, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611037, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611038, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611039, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611040, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611041, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611042, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611043, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611044, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611045, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611046, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611047, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611048, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611049, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611050, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611051, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611052, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611053, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611054, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611055, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611056, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611057, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611058, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611059, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611060, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611061, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611062, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611063, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611064, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611065, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611066, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611067, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611068, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611069, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611070, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611071, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611072, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611073, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611074, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611075, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611076, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611077, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611078, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611079, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611080, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611081, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611082, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611083, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611084, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611085, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611086, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611087, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611088, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611089, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611090, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611091, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611092, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611093, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611094, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611095, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611096, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611097, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611098, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611099, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611100, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611101, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611102, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611103, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611104, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611105, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611106, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611107, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611108, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611109, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611110, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611111, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611112, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611113, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611114, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611115, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611116, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611117, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611118, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611119, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611120, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611121, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611122, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611123, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611124, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611125, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611126, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611127, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611128, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611129, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611130, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611131, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611132, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0013942', 'enthesitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611133, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611134, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611135, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611136, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611137, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611138, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611139, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611140, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611141, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611142, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611143, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611144, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611145, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611146, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611147, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611148, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611149, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611150, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611151, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611152, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611153, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611154, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611155, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611156, 'HP:0033557', 'Anti-proteinase 3 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(611157, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0003049', 'abnormal lumbar vertebrae morphology', 0.4146341463414634, 8.941811350726098, 1.9255078073471226, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611158, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.4418604651162791, 8.941811350726098, 1.9877205342838962, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611159, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0031312', 'spondylolysis', 0.4166666666666667, 8.557298718460714, 1.8882640526928336, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611160, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0000160', 'kyphosis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611161, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004669', 'enlarged vertebral body', 0.4418604651162791, 8.941811350726098, 1.9877205342838962, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611162, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004656', 'absent sacral vertebrae', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611163, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004174', 'abnormal spine curvature', 0.4166666666666667, 8.557298718460714, 1.8882640526928336, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611164, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0003036', 'vertebral transformation', 0.43243243243243246, 8.941811350726098, 1.9664000693517127, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611165, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0000161', 'scoliosis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611166, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004610', 'small vertebrae', 0.4634146341463415, 8.941811350726098, 2.0356242864788037, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611167, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004687', 'split vertebrae', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611168, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004626', 'vertebral compression', 0.4318181818181818, 8.941811350726098, 1.9650029820923236, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611169, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004600', 'abnormal vertebral transverse process morphology', 0.4146341463414634, 8.941811350726098, 1.9255078073471226, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611170, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0013612', 'enlarged caudal vertebrae', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611171, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004670', 'small vertebral body', 0.4318181818181818, 8.941811350726098, 1.9650029820923236, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611172, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0008771', 'elongated vertebral column', 0.4186046511627907, 8.557298718460714, 1.8926502701072492, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611173, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004602', 'abnormal vertebral articular process morphology', 0.4146341463414634, 8.941811350726098, 1.9255078073471226, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611174, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0000137', 'abnormal vertebrae morphology', 0.4444444444444444, 8.941811350726098, 1.9935241102380699, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611175, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0010113', 'abnormal sacrum morphology', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611176, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004657', 'small sacral vertebrae', 0.4222222222222222, 8.941811350726098, 1.943046952390874, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611177, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0008832', 'hemivertebra', 0.43243243243243246, 8.941811350726098, 1.9664000693517127, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611178, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004643', 'abnormal vertebrae number', 0.425, 8.941811350726098, 1.9494280761440244, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611179, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004654', 'absent lumbar vertebrae', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611180, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.4473684210526316, 8.941811350726098, 2.000071005070778, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611181, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0000141', 'abnormal vertebral body morphology', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611182, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0031313', 'spondylolisthesis', 0.4166666666666667, 8.557298718460714, 1.8882640526928336, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611183, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0013972', 'occipital vertebra', 0.43243243243243246, 8.941811350726098, 1.9664000693517127, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611184, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0006322', 'abnormal perichondrium morphology', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611185, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0003050', 'abnormal sacral vertebrae morphology', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611186, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004599', 'abnormal vertebral arch morphology', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611187, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004703', 'abnormal vertebral column morphology', 0.42857142857142855, 8.557298718460714, 1.9150492778211121, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611188, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004707', 'enlarged lumbar vertebrae', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611189, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0004704', 'short vertebral column', 0.4186046511627907, 8.557298718460714, 1.8926502701072492, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611190, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0000162', 'lordosis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(611191, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0021136', 'abnormal vertebrae shape', 0.4523809523809524, 8.941811350726098, 2.011244673045098, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611192, 'HP:0030778', 'Modic type III vertebral endplate changes', 'MP:0005225', 'abnormal vertebrae development', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(611193, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0006322', 'abnormal perichondrium morphology', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611194, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0013614', 'abnormal areal bone mineral density', 0.41935483870967744, 4.825104621810128, 1.422473539450385, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611195, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0030222', 'hyperostosis', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611196, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611197, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0001259', 'abnormal body weight', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611198, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0030484', 'abnormal osteocyte lacuna morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611199, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010099', 'abnormal thoracic cage shape', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611200, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0002932', 'abnormal joint morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611201, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0005605', 'increased bone mass', 0.41935483870967744, 4.825104621810128, 1.422473539450385, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611202, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0031094', 'organomegaly', 0.43333333333333335, 3.067140347159989, 1.1528634569783167, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611203, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0004675', 'rib fractures', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611204, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0030486', 'abnormal osteocyte canaliculus morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611205, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010123', 'increased bone mineral content', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611206, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003201', 'extremity edema', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611207, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0005406', 'abnormal heart size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611208, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0008753', 'abnormal osteocyte morphology', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611209, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0013304', 'osteophytes', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611210, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0002632', 'vestigial tail', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611211, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010927', 'decreased osteoid volume', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611212, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0000067', 'osteopetrosis', 0.40625, 4.825104621810128, 1.4000709812757226, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611213, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0013613', 'abnormal volumetric bone mineral density', 0.41935483870967744, 4.825104621810128, 1.422473539450385, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611214, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003200', 'calcified joint', 0.46875, 4.825104621810128, 1.503917481603794, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611215, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010124', 'decreased bone mineral content', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611216, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611217, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0000013', 'abnormal adipose tissue distribution', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611218, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0012072', 'decreased susceptibility to osteoporosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611219, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003950', 'abnormal plasma membrane morphology', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611220, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0000166', 'abnormal chondrocyte morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611221, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010122', 'abnormal bone mineral content', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611222, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010926', 'increased osteoid volume', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611223, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010104', 'enlarged thoracic cage', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611224, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0000071', 'axial skeleton hypoplasia', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611225, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611226, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0012071', 'increased susceptibility to osteoporosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611227, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0002114', 'abnormal axial skeleton morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611228, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010875', 'increased bone volume', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611229, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0014167', 'ectopic bone', 0.40625, 4.825104621810128, 1.4000709812757226, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611230, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0000163', 'abnormal cartilage morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611231, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0002113', 'abnormal skeleton development', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611232, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010974', 'decreased periosteum thickness', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611233, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0002229', 'neurodegeneration', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611234, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0001256', 'abnormal body length', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611235, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010103', 'small thoracic cage', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611236, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0031348', 'bone fibrous dysplasia', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611237, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0009345', 'abnormal trabecular bone thickness', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611238, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0005508', 'abnormal skeleton morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611239, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611240, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003956', 'abnormal body size', 0.4482758620689655, 3.067140347159989, 1.1725719522526752, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611241, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0020009', 'abnormal bone mineral density of femur', 0.41935483870967744, 4.825104621810128, 1.422473539450385, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611242, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0002582', 'disorganized extraembryonic tissue', 0.43333333333333335, 3.067140347159989, 1.1528634569783167, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611243, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010973', 'increased periosteum thickness', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611244, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003198', 'calcified tendon', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611245, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003199', 'calcified muscle', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611246, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010928', 'abnormal osteoid thickness', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611247, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0001253', 'abnormal body height', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611248, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0031350', 'polyostotic fibrous dysplasia', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611249, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0011999', 'abnormal tail length', 0.41935483870967744, 3.067140347159989, 1.134116460326373, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611250, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0000566', 'synostosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611251, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010874', 'abnormal bone volume', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611252, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003189', 'fused joints', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611253, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010876', 'decreased bone volume', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611254, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003141', 'cardiac fibrosis', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611255, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0013328', 'visceromegaly', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611256, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0005422', 'osteosclerosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611257, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010119', 'abnormal bone mineral density', 0.43333333333333335, 4.825104621810128, 1.4459870917304398, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611258, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0009877', 'exostosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611259, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003988', 'disorganized embryonic tissue', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611260, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0010971', 'abnormal periosteum morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611261, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0003795', 'abnormal bone structure', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611262, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0000749', 'muscle degeneration', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(611263, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0013941', 'abnormal enthesis morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611264, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0002936', 'joint swelling', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611265, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0004986', 'abnormal osteoblast morphology', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611266, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0031349', 'monostotic fibrous dysplasia', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611267, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0000134', 'abnormal compact bone thickness', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611268, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0013844', 'abnormal perichondrial ossification', 0.4838709677419355, 4.825104621810128, 1.5279816892919078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611269, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0000358', 'abnormal cell morphology', 0.42857142857142855, 3.008048030199787, 1.1354133350961642, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(611270, 'HP:0008178', 'Abnormal cartilage matrix', 'MP:0005504', 'abnormal ligament morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(611271, 'HP:0003954', 'Angulated forearm bones', 'MP:0000552', 'abnormal radius morphology', 0.43137254901960786, 10.120647406075808, 2.089442382380429, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(611272, 'HP:0003954', 'Angulated forearm bones', 'MP:0005108', 'abnormal ulna morphology', 0.43137254901960786, 10.120647406075808, 2.089442382380429, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(611273, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002174', 'abnormal gastrulation movements', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611274, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003656', 'abnormal erythrocyte physiology', 0.4857142857142857, 13.237913458245556, 2.535713643083396, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611275, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013208', 'abnormal cilium physiology', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611276, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611277, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611278, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020845', 'abnormal DNA-templated transcription', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611279, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611280, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611281, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003192', 'increased cholesterol efflux', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611282, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611283, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611284, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010034', 'abnormal erythrocyte clearance', 0.4722222222222222, 13.237913458245556, 2.5002473699292596, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611285, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011811', 'decreased anoikis', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611286, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020426', 'abnormal beige fat cell physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611287, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012387', 'increased erythrocyte potassium:chloride symporter activity', 0.4146341463414634, 13.237913458245556, 2.3428382244836743, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611288, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0021001', 'impaired neuron physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611289, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611290, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611291, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008057', 'abnormal DNA replication', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611292, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003927', 'increased cellular glucose import', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611293, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611294, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611295, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611296, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011809', 'abnormal anoikis', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611297, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011703', 'increased fibroblast proliferation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611298, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010954', 'abnormal cellular respiration', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611299, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020455', 'increased erythrocyte aggregation', 0.4473684210526316, 13.237913458245556, 2.433562089170255, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611300, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611301, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003123', 'paternal imprinting', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611302, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003207', 'decreased cellular sensitivity to gamma-irradiation', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611303, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611304, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013210', 'abnormal primary cilium physiology', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611305, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611306, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0000313', 'abnormal cell death', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611307, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012555', 'decreased cell death', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611308, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611309, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611310, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611311, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012742', 'increased neural crest cell proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611312, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031469', 'abnormal pinocytosis', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611313, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611314, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012382', 'abnormal blood cell physiology', 0.4642857142857143, 5.816527256141925, 1.6433290941805234, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(611315, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611316, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611317, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002429', 'abnormal blood cell morphology/development', 0.43333333333333335, 9.120647406075808, 1.9880343414118504, 'UPHENO:0085189', 'abnormal blood cell'),
(611318, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008008', 'early cellular replicative senescence', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611319, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009967', 'abnormal neuron proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611320, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013503', 'abnormal embryonic tissue cell apoptosis', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611321, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611322, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011704', 'decreased fibroblast proliferation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611323, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005621', 'abnormal cell physiology', 0.5384615384615384, 7.733703155395898, 2.040662073705328, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611324, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009844', 'abnormal neural crest cell apoptosis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611325, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611326, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0006043', 'decreased apoptosis', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611327, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611328, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011706', 'abnormal fibroblast migration', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611329, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020363', 'abnormal germ cell physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611330, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611331, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611332, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005076', 'abnormal cell differentiation', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611333, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011805', 'decreased cell migration', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611334, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611335, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008007', 'abnormal cellular replicative senescence', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611336, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013209', 'abnormal motile cilium physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611337, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611338, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611339, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010957', 'abnormal aerobic respiration', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611340, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611341, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611342, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0021085', 'increased DNA replication', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611343, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611344, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611345, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012115', 'abnormal trophectoderm cell proliferation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611346, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611347, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611348, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008009', 'delayed cellular replicative senescence', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611349, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611350, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611351, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611352, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014055', 'abnormal sebocyte proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611353, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611354, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011806', 'decreased dermal fibroblast proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611355, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611356, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611357, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030939', 'abnormal autophagosome formation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611358, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611359, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030909', 'abnormal melanocyte adhesion', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611360, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012556', 'increased cell death', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611361, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004759', 'decreased mitotic index', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611362, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008058', 'abnormal DNA repair', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611363, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020423', 'abnormal mitochondrial biogenesis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611364, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611365, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611366, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611367, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611368, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611369, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611370, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012746', 'abnormal neural crest cell delamination', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611371, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0006036', 'abnormal mitochondrial physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611372, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611373, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012386', 'decreased erythrocyte potassium:chloride symporter activity', 0.4146341463414634, 13.237913458245556, 2.3428382244836743, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611374, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611375, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010953', 'abnormal fatty acid oxidation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611376, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010035', 'increased erythrocyte clearance', 0.4594594594594595, 13.237913458245556, 2.4662288137755195, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611377, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611378, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611379, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004811', 'abnormal neuron physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611380, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012241', 'abnormal hepatoblast physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611381, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020354', 'increased endoplasmic reticulum stress', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611382, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012384', 'abnormal erythrocyte ion transport', 0.4358974358974359, 13.237913458245556, 2.4021599724167824, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611383, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611384, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002950', 'abnormal neural crest cell migration', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611385, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012119', 'increased trophectoderm apoptosis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611386, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008406', 'increased cellular sensitivity to hydrogen peroxide', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611387, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611388, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008877', 'abnormal DNA methylation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611389, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012395', 'decreased erythrocyte calcium-activated potassium channel activity', 0.4146341463414634, 13.237913458245556, 2.3428382244836743, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611390, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009410', 'abnormal skeletal muscle satellite cell proliferation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611391, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014054', 'abnormal sebocyte physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611392, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611393, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008404', 'increased cellular sensitivity to methylmethanesulfonate', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611394, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611395, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611396, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611397, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020454', 'decreased erythrocyte aggregation', 0.4473684210526316, 13.237913458245556, 2.433562089170255, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611398, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611399, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030941', 'enhanced autophagy', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611400, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009567', 'mitotic nondisjunction', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611401, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611402, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008405', 'decreased cellular sensitivity to methylmethanesulfonate', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611403, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611404, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611405, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001577', 'anemia', 0.41935483870967744, 9.120647406075808, 1.955706425285441, 'UPHENO:0085189', 'abnormal blood cell'),
(611406, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611407, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030021', 'increased muscle cell glucose uptake', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611408, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611409, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020352', 'abnormal endoplasmic reticulum physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611410, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008260', 'abnormal autophagy', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611411, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004046', 'abnormal mitosis', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611412, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611413, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611414, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611415, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012388', 'abnormal erythrocyte sodium:hydrogen antiporter activity', 0.425, 13.237913458245556, 2.371942920846613, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611416, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611417, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611418, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008942', 'abnormal induced cell death', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611419, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611420, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012392', 'decreased erythrocyte sodium:potassium-exchanging ATPase activity', 0.4146341463414634, 13.237913458245556, 2.3428382244836743, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611421, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013211', 'abnormal nonmotile primary cilium physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611422, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014240', 'abnormal ribosome physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611423, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611424, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004966', 'abnormal inner cell mass proliferation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611425, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611426, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003174', 'increased lysosomal enzyme secretion', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611427, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030910', 'abnormal melanoblast apoptosis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611428, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004030', 'induced chromosome breakage', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611429, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014041', 'increased cellular sensitivity to cisplatin', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611430, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020345', 'abnormal myocardial fiber currents', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611431, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611432, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0000316', 'cellular necrosis', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611433, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030022', 'decreased muscle cell glucose uptake', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611434, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48148148148148145, 5.816527256141925, 1.6734844368456583, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(611435, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001931', 'abnormal oogenesis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611436, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030905', 'abnormal melanoblast proliferation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611437, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611438, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611439, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010094', 'abnormal chromosome stability', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611440, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012396', 'increased erythrocyte calcium-activated potassium channel activity', 0.4146341463414634, 13.237913458245556, 2.3428382244836743, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611441, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611442, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003787', 'abnormal imprinting', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611443, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030940', 'impaired autophagy', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611444, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611445, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013004', 'abnormal enteric neural crest cell proliferation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611446, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020848', 'abnormal exocytosis', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611447, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004760', 'increased mitotic index', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611448, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011804', 'increased cell migration', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611449, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611450, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001648', 'abnormal apoptosis', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611451, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003090', 'abnormal muscle precursor cell migration', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611452, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012389', 'decreased erythrocyte sodium:hydrogen antiporter activity', 0.4146341463414634, 13.237913458245556, 2.3428382244836743, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611453, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014172', 'decreased fatty acid oxidation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611454, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003453', 'abnormal keratinocyte physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611455, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611456, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011810', 'increased anoikis', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611457, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003674', 'oxidative stress', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611458, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011005', 'abnormal epidermal stem cell physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611459, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010381', 'abnormal dosage compensation', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611460, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003926', 'decreased cellular glucose uptake', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611461, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611462, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611463, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030951', 'abnormal endocytosis', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611464, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008408', 'decreased cellular sensitivity to hydroxyurea', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611465, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020415', 'abnormal fibroblast chemotaxis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611466, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002879', 'increased cellular sensitivity to X-ray irradiation', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611467, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611468, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611469, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611470, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611471, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012758', 'abnormal cranial neural crest cell proliferation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611472, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611473, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003186', 'abnormal redox activity', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611474, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611475, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011709', 'increased fibroblast cell migration', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611476, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008943', 'increased sensitivity to induced cell death', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611477, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611478, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611479, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611480, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611481, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611482, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611483, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611484, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008402', 'increased cellular sensitivity to alkylating agents', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611485, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020453', 'abnormal erythrocyte aggregation', 0.4594594594594595, 13.237913458245556, 2.4662288137755195, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611486, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012201', 'decreased endothelial cell proliferation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611487, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010036', 'decreased erythrocyte clearance', 0.4594594594594595, 13.237913458245556, 2.4662288137755195, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611488, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611489, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011825', 'decreased cell chemotaxis', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611490, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030016', 'increased adipocyte glucose uptake', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611491, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611492, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004029', 'spontaneous chromosome breakage', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611493, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009876', 'increased cellular sensitivity to thiophosphamide', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611494, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010947', 'abnormal single-strand DNA break repair', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611495, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012745', 'abnormal neural crest cell physiology', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611496, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008409', 'increased cellular sensitivity to hydroxyurea', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611497, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031126', 'gangrene', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611498, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012117', 'decreased trophectoderm cell proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611499, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010741', 'abnormal melanocyte proliferation', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611500, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003193', 'decreased cholesterol efflux', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611501, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611502, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012385', 'abnormal erythrocyte potassium:chloride symporter activity', 0.425, 13.237913458245556, 2.371942920846613, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611503, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008866', 'chromosomal instability', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611504, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611505, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611506, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611507, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611508, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020846', 'abnormal cell motility', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611509, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014171', 'increased fatty acid oxidation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611510, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611511, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008387', 'hypochromic anemia', 0.40625, 9.120647406075808, 1.9249059739941317, 'UPHENO:0085189', 'abnormal blood cell'),
(611512, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611513, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013272', 'abnormal translation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611514, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010763', 'abnormal hematopoietic stem cell physiology', 0.4838709677419355, 7.733703155395898, 1.9344545562070652, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611515, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008403', 'decreased cellular sensitivity to alkylating agents', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611516, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030904', 'abnormal melanoblast physiology', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611517, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611518, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004130', 'abnormal muscle cell glucose uptake', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611519, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011245', 'abnormal fetal derived definitive erythrocyte physiology', 0.4594594594594595, 13.237913458245556, 2.4662288137755195, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611520, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010948', 'abnormal double-strand DNA break repair', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611521, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0021086', 'decreased DNA replication', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611522, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611523, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611524, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009796', 'abnormal base-excision repair', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611525, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014043', 'decreased cellular sensitivity to cisplatin', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611526, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031470', 'abnormal macropinocytosis', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611527, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008407', 'decreased cellular sensitivity to hydrogen peroxide', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611528, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611529, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611530, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611531, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0006042', 'increased apoptosis', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611532, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611533, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611534, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010095', 'increased chromosomal stability', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611535, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611536, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002810', 'microcytic anemia', 0.40625, 9.120647406075808, 1.9249059739941317, 'UPHENO:0085189', 'abnormal blood cell'),
(611537, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012741', 'decreased neural crest cell proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611538, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611539, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011255', 'abnormal anterior visceral endoderm cell migration', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611540, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010380', 'abnormal inner cell mass apoptosis', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611541, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611542, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012112', 'increased inner cell mass proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611543, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0000729', 'abnormal myogenesis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611544, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611545, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003122', 'maternal imprinting', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611546, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611547, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005006', 'abnormal osteoblast physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611548, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009797', 'abnormal mismatch repair', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611549, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012197', 'impaired myofibroblast differentiation', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611550, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012390', 'increased erythrocyte sodium:hydrogen antiporter activity', 0.4146341463414634, 13.237913458245556, 2.3428382244836743, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611551, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611552, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611553, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001930', 'abnormal meiosis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611554, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031085', 'increased erythrocyte osmotic fragility', 0.4473684210526316, 13.237913458245556, 2.433562089170255, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611555, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031322', 'decreased skeletal muscle satellite cell proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611556, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031084', 'decreased erythrocyte osmotic fragility', 0.4473684210526316, 13.237913458245556, 2.433562089170255, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611557, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611558, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009842', 'abnormal neural crest cell proliferation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611559, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611560, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030017', 'decreased adipocyte glucose uptake', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611561, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003173', 'decreased lysosomal enzyme secretion', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611562, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012200', 'increased endothelial cell proliferation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611563, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014242', 'abnormal ribosome biogenesis', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611564, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611565, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012113', 'decreased inner cell mass proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611566, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0000350', 'abnormal cell proliferation', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611567, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014243', 'abnormal ribosome assembly', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611568, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010951', 'abnormal lipid oxidation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611569, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011708', 'decreased fibroblast cell migration', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611570, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003077', 'abnormal cell cycle', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611571, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011807', 'decreased lung fibroblast proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611572, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020414', 'abnormal fibroblast physiology', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611573, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611574, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030938', 'abnormal reticulophagy', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611575, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012391', 'abnormal erythrocyte sodium:potassium-exchanging ATPase activity', 0.425, 13.237913458245556, 2.371942920846613, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611576, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003566', 'abnormal cell adhesion', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611577, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011702', 'abnormal fibroblast proliferation', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611578, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611579, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013500', 'abnormal fibroblast apoptosis', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611580, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611581, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611582, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020847', 'abnormal peroxisome physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611583, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611584, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031127', 'dry gangrene', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611585, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004587', 'decreased cellular sensitivity to X-ray irradiation', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611586, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004768', 'abnormal axonal transport', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611587, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011518', 'abnormal cell chemotaxis', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611588, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611589, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012394', 'abnormal erythrocyte calcium-activated potassium channel activity', 0.425, 13.237913458245556, 2.371942920846613, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611590, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611591, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611592, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002811', 'macrocytic anemia', 0.40625, 9.120647406075808, 1.9249059739941317, 'UPHENO:0085189', 'abnormal blood cell'),
(611593, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004185', 'abnormal adipocyte glucose uptake', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611594, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020239', 'abnormal skeletal muscle cell apoptosis', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611595, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611596, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611597, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003091', 'abnormal cell migration', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611598, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611599, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003891', 'increased allantois apoptosis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611600, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012116', 'increased trophectoderm cell proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611601, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611602, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611603, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611604, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0002007', 'increased cellular sensitivity to gamma-irradiation', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611605, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611606, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611607, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011824', 'increased cell chemotaxis', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611608, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611609, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611610, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004028', 'chromosome breakage', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611611, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031471', 'abnormal micropinocytosis', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611612, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611613, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0000351', 'increased cell proliferation', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611614, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003172', 'abnormal lysosome physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611615, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003657', 'abnormal erythrocyte osmotic lysis', 0.4594594594594595, 13.237913458245556, 2.4662288137755195, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611616, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0014046', 'abnormal mitophagy', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611617, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0031323', 'increased skeletal muscle satellite cell proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611618, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020353', 'abnormal endoplasmic reticulum stress', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611619, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0010163', 'hemolysis', 0.4722222222222222, 13.237913458245556, 2.5002473699292596, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611620, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611621, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611622, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611623, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611624, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0003925', 'abnormal cellular glucose uptake', 0.5185185185185185, 7.733703155395898, 2.0025154937722385, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611625, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0000352', 'decreased cell proliferation', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611626, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0001585', 'hemolytic anemia', 0.40625, 9.120647406075808, 1.9249059739941317, 'UPHENO:0085189', 'abnormal blood cell'),
(611627, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(611628, 'HP:0005546', 'Increased red cell osmotic resistance', 'MP:0012393', 'increased erythrocyte sodium:potassium-exchanging ATPase activity', 0.4146341463414634, 13.237913458245556, 2.3428382244836743, 'UPHENO:0085599', 'abnormality of erythrocyte physiology'),
(611629, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0013328', 'visceromegaly', 0.5, 5.9605885577567275, 1.726352883647594, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611630, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0004735', 'enlarged thoracic cavity', 0.4444444444444444, 5.9605885577567275, 1.6276211076642195, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611631, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0000434', 'megacephaly', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611632, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010964', 'increased compact bone volume', 0.40476190476190477, 10.365561281341517, 2.0483125562672417, 'UPHENO:0084715', 'abnormally increased volume of anatomical entity'),
(611633, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010786', 'stomach fundus hypertrophy', 0.4186046511627907, 10.843381614401354, 2.1305140173492165, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611634, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0008772', 'increased heart ventricle size', 0.46153846153846156, 10.843381614401354, 2.2371047512768016, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611635, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0012160', 'expanded anterior visceral endoderm', 0.47058823529411764, 5.9605885577567275, 1.6748083026749803, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611636, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001268', 'barrel chest', 0.47058823529411764, 5.9605885577567275, 1.6748083026749803, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611637, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0004574', 'broad limb buds', 0.40476190476190477, 5.9605885577567275, 1.5532608210276946, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611638, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0004127', 'thick hypodermis', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611639, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0003956', 'abnormal body size', 0.45161290322580644, 4.671736632292707, 1.4525207549691197, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(611640, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001281', 'increased vibrissae length', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611641, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0005355', 'enlarged thyroid gland', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611642, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0004545', 'enlarged esophagus', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611643, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0009461', 'skeletal muscle hypertrophy', 0.43902439024390244, 10.843381614401354, 2.181859070023657, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611644, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001214', 'skin hyperplasia', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611645, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001222', 'epidermal hyperplasia', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611646, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0000274', 'enlarged heart', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611647, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001253', 'abnormal body height', 0.4117647058823529, 4.671736632292707, 1.3869593578601431, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(611648, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010104', 'enlarged thoracic cage', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611649, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001200', 'thick skin', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611650, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0002758', 'long tail', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611651, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0000573', 'enlarged hind paws', 0.4146341463414634, 5.9605885577567275, 1.5720889123513833, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611652, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0008726', 'enlarged heart left atrium', 0.4090909090909091, 10.843381614401354, 2.1061644860397535, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611653, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0002844', 'aortic hypertrophy', 0.4186046511627907, 10.843381614401354, 2.1305140173492165, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611654, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0012483', 'increased corticospinal tract size', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611655, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010878', 'increased trabecular bone volume', 0.4146341463414634, 10.365561281341517, 2.073141493781639, 'UPHENO:0084715', 'abnormally increased volume of anatomical entity'),
(611656, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001264', 'increased body size', 0.48484848484848486, 5.9605885577567275, 1.6999948032372232, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611657, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0003285', 'gastric hypertrophy', 0.4186046511627907, 10.843381614401354, 2.1305140173492165, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611658, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0004556', 'enlarged allantois', 0.47058823529411764, 5.9605885577567275, 1.6748083026749803, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611659, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010856', 'dilated respiratory conducting tube', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611660, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0002809', 'increased spinal cord size', 0.4444444444444444, 5.9605885577567275, 1.6276211076642195, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611661, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001259', 'abnormal body weight', 0.4117647058823529, 4.671736632292707, 1.3869593578601431, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(611662, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010944', 'respiratory epithelium hypertrophy', 0.5, 10.843381614401354, 2.3284524489885285, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611663, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010926', 'increased osteoid volume', 0.4473684210526316, 10.365561281341517, 2.1534216456045123, 'UPHENO:0084715', 'abnormally increased volume of anatomical entity'),
(611664, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010127', 'hypervolemia', 0.4146341463414634, 10.365561281341517, 2.073141493781639, 'UPHENO:0084715', 'abnormally increased volume of anatomical entity'),
(611665, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0011999', 'abnormal tail length', 0.42424242424242425, 4.671736632292707, 1.407817059957009, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(611666, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001256', 'abnormal body length', 0.4117647058823529, 4.671736632292707, 1.3869593578601431, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(611667, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0000548', 'long limbs', 0.4722222222222222, 5.9605885577567275, 1.677713436346098, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611668, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0020242', 'enlarged paws', 0.4857142857142857, 5.9605885577567275, 1.7015119787317259, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611669, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001625', 'cardiac hypertrophy', 0.43902439024390244, 10.843381614401354, 2.181859070023657, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611670, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0031094', 'organomegaly', 0.5333333333333333, 5.9605885577567275, 1.7829695914784753, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611671, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0003112', 'enlarged parathyroid gland', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611672, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0005406', 'abnormal heart size', 0.4117647058823529, 4.671736632292707, 1.3869593578601431, 'UPHENO:0075195', 'abnormal size of anatomical entity'),
(611673, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0020302', 'large horns', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611674, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0002975', 'vascular smooth muscle hypertrophy', 0.4090909090909091, 10.843381614401354, 2.1061644860397535, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611675, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0011408', 'renal tubule hypertrophy', 0.4186046511627907, 10.843381614401354, 2.1305140173492165, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611676, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001267', 'enlarged chest', 0.48484848484848486, 5.9605885577567275, 1.6999948032372232, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611677, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0030345', 'enlarged maxillary prominence', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611678, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0000466', 'esophageal epithelium hyperplasia', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611679, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0000588', 'thick tail', 0.45714285714285713, 5.9605885577567275, 1.6507090850740274, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611680, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0008725', 'enlarged heart atrium', 0.46153846153846156, 10.843381614401354, 2.2371047512768016, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611681, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0004938', 'dilated vasculature', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611682, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010973', 'increased periosteum thickness', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611683, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0003585', 'large ureter', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611684, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0010875', 'increased bone volume', 0.4857142857142857, 10.365561281341517, 2.2438139837772764, 'UPHENO:0084715', 'abnormally increased volume of anatomical entity'),
(611685, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0005238', 'increased brain size', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611686, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0006296', 'arachnodactyly', 0.4146341463414634, 5.9605885577567275, 1.5720889123513833, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611687, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0000291', 'enlarged pericardium', 0.4444444444444444, 5.9605885577567275, 1.6276211076642195, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611688, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0001183', 'overexpanded pulmonary alveolus', 0.40476190476190477, 10.365561281341517, 2.0483125562672417, 'UPHENO:0084715', 'abnormally increased volume of anatomical entity'),
(611689, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0000655', 'dilated sex gland', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611690, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0000053', 'excessive ear growth', 0.4090909090909091, 10.843381614401354, 2.1061644860397535, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611691, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0008727', 'enlarged heart right atrium', 0.4090909090909091, 10.843381614401354, 2.1061644860397535, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(611692, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0004971', 'dermal hyperplasia', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611693, 'HP:0010484', 'Hypertrophy of the upper limb', 'MP:0003398', 'increased skeletal muscle size', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(611694, 'HP:0031192', 'Abnormal morphology of left ventricular trabeculae', 'MP:0020323', 'abnormal heart apex size', 0.43243243243243246, 8.197756331773574, 1.8828105881997854, 'UPHENO:0015324', 'abnormal anatomical entity morphology in the heart'),
(611695, 'HP:0031192', 'Abnormal morphology of left ventricular trabeculae', 'MP:0003141', 'cardiac fibrosis', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(611696, 'HP:0031192', 'Abnormal morphology of left ventricular trabeculae', 'MP:0005406', 'abnormal heart size', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(611697, 'HP:0031192', 'Abnormal morphology of left ventricular trabeculae', 'MP:0010534', 'calcified myocardium', 0.4090909090909091, 9.93472192593978, 2.0159872083542822, 'UPHENO:0076781', 'abnormal myocardium morphology'),
(611698, 'HP:0031192', 'Abnormal morphology of left ventricular trabeculae', 'MP:0020135', 'abnormal heart ventricle wall thickness', 0.42105263157894735, 8.197756331773574, 1.8578715985062695, 'UPHENO:0015324', 'abnormal anatomical entity morphology in the heart'),
(611699, 'HP:0031192', 'Abnormal morphology of left ventricular trabeculae', 'MP:0005608', 'cardiac interstitial fibrosis', 0.4166666666666667, 7.506484928906078, 1.768531044033682, 'UPHENO:0076810', 'abnormal heart morphology'),
(611700, 'HP:0031192', 'Abnormal morphology of left ventricular trabeculae', 'MP:0002190', 'disorganized myocardium', 0.4186046511627907, 9.93472192593978, 2.039294193148048, 'UPHENO:0076781', 'abnormal myocardium morphology'),
(611701, 'HP:0011258', 'Tragal bridge of crus of helix', 'MP:0000022', 'abnormal ear shape', 0.44642857142857145, 11.115294171581601, 2.2275962152121513, 'UPHENO:0005986', 'abnormal shape of external ear'),
(611702, 'HP:0011258', 'Tragal bridge of crus of helix', 'MP:0003735', 'cup-shaped ears', 0.4262295081967213, 12.607147267911277, 2.318089338176047, 'UPHENO:0083647', 'abnormal helix of outer ear morphology'),
(611703, 'HP:0032964', 'Uric acid crystalluria', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611704, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011417', 'abnormal renal transport', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611705, 'HP:0032964', 'Uric acid crystalluria', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611706, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011421', 'cylindruria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611707, 'HP:0032964', 'Uric acid crystalluria', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611708, 'HP:0032964', 'Uric acid crystalluria', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611709, 'HP:0032964', 'Uric acid crystalluria', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5185185185185185, 8.666588959537362, 2.119855388442396, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611710, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011900', 'podocyturia', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611711, 'HP:0032964', 'Uric acid crystalluria', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611712, 'HP:0032964', 'Uric acid crystalluria', 'MP:0010107', 'abnormal renal reabsorption', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611713, 'HP:0032964', 'Uric acid crystalluria', 'MP:0008055', 'increased urine osmolality', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611714, 'HP:0032964', 'Uric acid crystalluria', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611715, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011923', 'abnormal bladder urine volume', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611716, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011466', 'increased urine urea nitrogen level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611717, 'HP:0032964', 'Uric acid crystalluria', 'MP:0009645', 'crystalluria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611718, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011758', 'renal ischemia', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611719, 'HP:0032964', 'Uric acid crystalluria', 'MP:0013305', 'isosthenuria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611720, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011418', 'leukocyturia', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611721, 'HP:0032964', 'Uric acid crystalluria', 'MP:0013284', 'abnormal renal glomerular filtration', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611722, 'HP:0032964', 'Uric acid crystalluria', 'MP:0009349', 'increased urine pH', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611723, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011297', 'absent tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611724, 'HP:0032964', 'Uric acid crystalluria', 'MP:0002988', 'decreased urine osmolality', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611725, 'HP:0032964', 'Uric acid crystalluria', 'MP:0004052', 'decreased renal sympathetic nerve activity', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611726, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011442', 'abnormal renal sodium ion transport', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611727, 'HP:0032964', 'Uric acid crystalluria', 'MP:0002987', 'abnormal urine osmolality', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611728, 'HP:0032964', 'Uric acid crystalluria', 'MP:0031480', 'abnormal urine xanthine level', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611729, 'HP:0032964', 'Uric acid crystalluria', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611730, 'HP:0032964', 'Uric acid crystalluria', 'MP:0001756', 'abnormal urination', 0.5, 8.666588959537362, 2.081656667120849, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611731, 'HP:0032964', 'Uric acid crystalluria', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611732, 'HP:0032964', 'Uric acid crystalluria', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611733, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011444', 'abnormal renal water homeostasis', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611734, 'HP:0032964', 'Uric acid crystalluria', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611735, 'HP:0032964', 'Uric acid crystalluria', 'MP:0003606', 'kidney failure', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611736, 'HP:0032964', 'Uric acid crystalluria', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611737, 'HP:0032964', 'Uric acid crystalluria', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611738, 'HP:0032964', 'Uric acid crystalluria', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611739, 'HP:0032964', 'Uric acid crystalluria', 'MP:0009348', 'abnormal urine pH', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611740, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011762', 'renal/urinary system inflammation', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611741, 'HP:0032964', 'Uric acid crystalluria', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611742, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011432', 'decreased urine flow rate', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611743, 'HP:0032964', 'Uric acid crystalluria', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611744, 'HP:0032964', 'Uric acid crystalluria', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611745, 'HP:0032964', 'Uric acid crystalluria', 'MP:0014037', 'stranguria', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611746, 'HP:0032964', 'Uric acid crystalluria', 'MP:0006273', 'abnormal urine organic cation level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611747, 'HP:0032964', 'Uric acid crystalluria', 'MP:0009350', 'decreased urine pH', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611748, 'HP:0032964', 'Uric acid crystalluria', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611749, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011296', 'decreased tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611750, 'HP:0032964', 'Uric acid crystalluria', 'MP:0031404', 'increased tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611751, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011856', 'abnormal glomerular filtration barrier function', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611752, 'HP:0032964', 'Uric acid crystalluria', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611753, 'HP:0032964', 'Uric acid crystalluria', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611754, 'HP:0032964', 'Uric acid crystalluria', 'MP:0003633', 'abnormal nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611755, 'HP:0032964', 'Uric acid crystalluria', 'MP:0004040', 'abnormal susceptibility to kidney reperfusion injury', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611756, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611757, 'HP:0032964', 'Uric acid crystalluria', 'MP:0003589', 'abnormal ureter physiology', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611758, 'HP:0032964', 'Uric acid crystalluria', 'MP:0031483', 'decreased urine hypoxanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611759, 'HP:0032964', 'Uric acid crystalluria', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611760, 'HP:0032964', 'Uric acid crystalluria', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(611761, 'HP:0032964', 'Uric acid crystalluria', 'MP:0031479', 'increased urine xanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611762, 'HP:0032964', 'Uric acid crystalluria', 'MP:0011420', 'pyuria', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(611763, 'HP:0032964', 'Uric acid crystalluria', 'MP:0010386', 'abnormal urinary bladder physiology', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
